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UNDER-REGULATED HEALTH CARE
PHENOMENA IN A FLAT WORLD:
MEDICAL TOURISM AND OUTSOURCING
NICOLAS

P.

TERRY*

INTRODUCTION

When a politician hails the importance of a global economyl or
a popularizer2 reports that our social and economic worlds have
been flattened? patients, health care providers, and health lawyers
may nod sagely in agreement. In their hearts, however, they know
that health care is in denial. And they have good reason to be skep
tical. Domestic health care seems resistant to market functioning
and there is little evidence it is ready to take its place in the global
economy. Doctors are subjected to state rather than nationallicen
sure and discouraged from reaching beyond state or national bor
ders with the Internet technologies used by every other industry.
Hospitals are hampered by immigration policies when they seek to
overcome physician shortages. Patients are denied access to drugs
or treatments that are cheaper across nearby borders.
Yet, health care is becoming more global in ways that patients
and even some providers do not realize. Modern health care may
still appear to be local, but how many patients know that, increas
ingly, their prescription drugs are being tested on foreign popula
tions, that there is little tracking of exactly where or by whom the
* Chester A. Myers Professor of Law, Co-Director, Center for Health Law Stud
ies, Professor of Health Management & Policy, Saint Louis University, e-mail:
terry@slu.edu. I thank Professor Margaret H. McDermott, SLU Law Library, and Nat
alie Kean, SLU J.D. candidate, for their enthusiastic and valuable research assistance
and Michael Henderson, SLU J.D.IM.H.A. candidate, for his editorial suggestions.
Sandra Johnson, Tim Jost, Tom McLean, Kevin Outterson, and Kandis Scott were ex
ceptionally generous with their time in making suggestions or commenting on earlier
drafts. Copyright © 2007, Nicolas Paul Terry. All Rights Reserved.
1. See, e.g., Address Before a Joint Session of the Congress on the State of the
Union, 42 WKLY. COMPo PRES. Doc. 145, H17 (Jan. 31, 2006), available at http://www.
gpoaccess.gov/sou/06sou.pdf ("With open markets and a level playing field, no one can
out-produce or out-compete the American worker.").
2. See Confusing Columbus, THE ECONOMIST, Mar. 31, 2005, at 77.
3. THOMAS L. FRIEDMAN, THE WORLD Is FLAT: A BRIEF HISTORY OF THE
TWENTY-FIRST CENTURY (2005).
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history they just gave their doctor is being transcribed and
processed, or that their CAT scan performed in a U.S. emergency
room is analyzed a few minutes later by a radiologist on the other
side of the world?
This Article examines two intersecting phenomena: medical
tourism and the outsourcing of health care goods and services.
"Medical Tourism" (Part I) involves the resident of one state or
country physically experiencing health care in another place. "Out
sourcing" (Part II) involves care that appears domestic but has been
dis aggregated to allow some components to be performed non-do
mestically. Frequently the patient (or in the case of final benefi
ciaries of a clinical trial, a domestic user of a subsequently approved
drug) does not know that care has been outsourced.
These two phenomena currently operate outside, and may be
disruptive of, contemporary Western health care regulation. While
health care, particularly in the U.S., is our most highly regulated
industry, medical tourism and outsourcing appear to operate
outside our traditional regulatory matrix. Having examined the ex
tent to which this is an accurate intuition, this Article questions (in
Part III) the extent to which we do or will enjoy increased trading
of health services and addresses some of the issues that must be
considered in approaching any regulatory questions posed by medi
cal tourism and outsourcing.
I.

MEDICAL TOURISM

The terms "medical tourism" and "health tourism" refer to
treatments or surgery that have been planned in advance to take
place outside a patient's usual place of residence. 4 Originally, such
tourism literally and rather quaintly applied to vacations at Euro
pean spas. As communications and travel improved, medical tour
ism was used, somewhat pejoratively, to describe the travel of
patients from less-developed countries seeking superior health care
in industrialized countries-a transfer that continues today with

4.
MED.

J.

Atul D. Garud, Medical Tourism and its Impact on Our Healthcare, 18
INDIA 318, 318-19 (2005).
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major medical centers in Europe 5 and the U.S.,6 attracting high
profit self-payers from other countries. 7
Today, however, it is more likely that the journey is reversed,
as patients travel from industrialized countries to less-developed
nations. 8 Such patients are attracted by the lower costs of proce
dures in less-developed countries, the opportunity to avoid their
home country's health care rationing (e.g., waiting lists for certain
surgical procedures),9 the need for a procedure still under regula
tory review in their home country,lO or a belief in the healing poten
tial of alternative procedures or medicines such as laetrile. l l
Patients who fall ill while visiting abroad (e.g., "snowbirds") are
generally not viewed as medical tourists. There are, however, some
unplanned scenarios that raise similar issues to those raised by
planned medical tourism-for example, the accident victim who

5. See, e.g., Munich Airport, Doctors and Health Insurers, http://www.munich
airport.de/EN I Areas/ConsumerIService/aerzte_und_Krankenkassen/index.h tml (last
visited Mar. 18, 2007) (listing available medical services on the Munich International
Airport website).
6. See, e.g., Johns Hopkins Int'l, http://www.jhintl.net/jhi/english/default.asp (last
visited Mar. 18, 2007); Philadelphia Int'l Medicine, http://www.philadelphiamedicine.
com (last visited Mar. 18, 2007); Mayo Clinic, Services for International Patients, http://
www.mayoclinic.org/english/services.html(last visited Mar. 18, 2007).
7. Steven Findlay, U.S. Hospitals Attracting Patients from Abroad, USA TODAY,
July 22,1997, at lA, available at 1997 WLNR 3052799 (Westlaw) (reporting that gener
ally there were increases in tourism traffic at leading U.S. medical centers, and that
specifically, 6,000 medical tourists were treated at Johns Hopkins in 1996, and a pro
jected 7,200 would be treated at the Mayo Clinic in 1997).
8. See Peter Foster, Britons Flock to India for Fast, Cheap Surgery, DAILY TELE
GRAPH (London), Aug. 27, 2005, at 4, available at 2005 WLNR 13494018 (Westlaw);
Prithi Yelaja, India Offers Surgery in a Hurry, TORONTO STAR, June 17, 2006, at A01,
available at 2006 WLNR 10481733 (Westlaw).
9. See NHS Waiting Lists at 17-Year Low, BBC NEWS, Nov. 12,2004, http://news.
bbc.co.uk/2/hilhealth/4006181.stm (noting September 2004 wait list of 856,600 people, a
decline of 300,000 since March 1997). But see Brian Donelly, Patients Still Wait 234
Days for Hip Operations, THE HERALD (Scotland), Apr. 24, 2006, available at http://
www.theherald.co.uk/news/60630.html(noting a delay of up to seven months for hip
replacement surgery).
10. Jean P. Fisher, Hip Patients Find Surgeons Overseas: Delay in FDA Approval
for Hip Resurfacing Means Lost Opportunity at Duke, NEWS & OBSERVER (Raleigh,
N.C.), Apr. 10,2006, available at 2006 WLNR 6007736 (Westlaw).
11. See, e.g., Barron H. Lerner, McQueen's Legacy of Laetrile, N.Y. TIMES, Nov.
15, 2005, at F5, available at 2005 WLNR 18424239 (Westlaw); Patients, Like King, Seek
Hope in Mexico, FT. WAYNE J. GAZETTE (Fort Wayne, Ind.), Feb. 5, 2006, at A10,
available at 2006 WLNR 2095649 (Westlaw); see also Rutherford v. United States, 616
F.2d 455, 456-57 (10th Cir. 1980) (upholding the FDA's right to prohibit the importation
of laetrile).
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crosses a nearby national border to benefit from superior emer
gency services. 12
Throughout the discussion that follows it bears remembering
that there is limited data as to the number of medical tourists (and
only slightly more regarding outsourcing). Stories about individuals
forced to leave their own countries for better health care are media
friendly and tempting cudgels for policy makers wishing to beat on
aspects of health care, immigration, or other domestic policies. Af
ter collecting and analyzing data on medical tourism from Canada
to the United States, Steven Katz and colleagues note that the phe
nomenon (and its assumed rationing cause) was used to support
U.S. criticisms of universal coverage,13 Canadian attacks on the
under-funding of that country's Medicare system, and Canadian
proposals to increase the level of private participation in health care
financing (for example, by re-capturing the private dollars spent
south of the border).14 Notwithstanding the many political constit
uents leveraging the tourism phenomenon, the same researchers
found that, for the period of 1994-1998, the numbers of Canadian
medical tourists seeking care in the U.S. was "almost indetectible"
relative to domestic health care. 15
A.

International Tourism

Several regions and countries have explicitly established them
selves as destinations for medical tourism. 16 For example, the city
of Bogota, Colombia promotes itself as a high-quality destination
for medical tourists in Latin America.17 South African hospitals of
fer "medical safaris," combining vacation with plastic surgery,18
12. See, e.g., Guerrero v. Copper Queen Hosp., 537 P.2d 1329 (Ariz. 1975).
13. See, e.g., Merrill Matthews, Jr., Americas: On a Bus to Bangor, Canadians
Seeking Health Care, WALL ST. J., July 5, 2002, at A13, available at LEXIS.
14. Steven J. Katz et aI., Phantoms in the Snow: Canadians' Use of Health Care
Services in the United States, HEALTH AFF., May-June 2002, at 19, 27, available at http://
content.healthaffairs.orglcgilreprintl2113/19.
15. Id.
16. Ramola Talwar Badam, Foreign Surgeons Attract U.S. Patients, SEATTLE
TIMES, Sept. 25, 2005, at AI, available at 2005 WLNR 15132786 (Westlaw) (reporting
2004 figures for foreign patients treated in India (150,000), Singapore (200,000), and
Thailand (600,000».
17. Owain Johnson, Bogota Launches Health Tourism Project, BRIT. MED. J., July
6, 2002, at 10, available at http://www.bmj.com!cgilcontentlfuI1l32517354/10/e.
18. Medical Tourism: Need Surgery, Will Travel, CBC NEWS ONLINE, June 18,
2004, http://www.cbc.ca/newslbackgroundlhealthcare/medicaltourism.html [hereinafter
Medical Tourism].
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while Malaysian hospitals propose surgery in a resort setting. 19
Bumrungrad International HospitaPO in Bangkok, Thailand, at
tracted 55,000 patients from the United States in 2005, 83 percent
for non-cosmetic procedures. 21 Mexico, often vilified in the highly
politicized immigration debate as an exporter of undocumented pa
tients, is developing a strong presence in offering low-cost dental
services to patients from across its northern border,22 while, for in
stance, Irish dental patients are offered cut-price cosmetic surgery23
in "Hungary[,] the dental capital of the world. "24
The largest number of press reports focus on medical tourism
services provided in India,25 where the finance minister has urged
his country to become a "global health destination,"26 and the head
of one state, Kerala, declared 2006 to be "The Year of Medical
Tourism."27 Analysts have predicted a $2.1 billion annual medical
tourism revenue for India by 2012.28 Apollo Hospitals, the largest
private health care group in Asia, has over seven thousand beds in
thirty-eight hospitals (located in several countries, including India,
Sri Lanka, Bangladesh, Ghana, Nigeria, Qatar, and Kuwait) and ac
19. Eric Paul Erickson, Over The Ocean, Under the Knife: Vacationers Are Mak
ing the Time to Work a Little Surgery into Exotic Trips, CHI. SUN-TIMES, Nov. 27, 2005,
at 1C, available at 2005 WLNR 20723934 (Westlaw) (noting the rise of Penang as
center, and the role of intermediary Beautiful Holidays). See generally Beautiful Holi
days, Welcome to Beautiful Holidays, http://www.beautiful-holidays.com (last visited
Mar. 18, 2007).
20. See generally Bumrungrad International, Welcome, http://www.bumrungrad.
com (last visited Mar. 18, 2007).
21. Unmesh Kher, Outsourcing Your Heart: Elective Surgery in India? Medical
Tourism is Booming, and U.S. Companies Trying to Contain Health-Care Costs Are
Starting to Take Notice, TIME, May 29,2006, at 44, 44 available at http://www.time.com!
time/magazine/article/0,9171 ,1196429,00.html.
22. Id.
23. Kreativ Dental Clinic, Kreativ Dental Clinic Tours Ireland, http://
www.kreativdentie (last visited Mar. 18, 2007).
24. Victoria Colliver, Dental Work Too Expensive? Go Overseas, S.F. CHRON.,
Apr. 5, 2006, at AI, available at 2006 WLNR 5689178 (Westlaw).
25. See, e.g., K. V. Prasad, Gearing Up for More Medical Tourists, THE HINDU
(India-Online Ed.), Jan. 31, 2006, http://www.hindu.com/2006/01l31/stories/2006013111
110100.htm; Americans and Europeans Are Trekking to India for Surgery, According to
Bloomberg Markets Magazine; 'Medical Tourism' is a Growing Business in India,
Bloomberg Markets Says, PR NEWSWIRE U.S., Jan. 27, 2005, available at LEXIS.
26. Ray Marcelo, India Fosters Growing 'Medical Tourism' Sector, FIN. TIMES,
July 2, 2003, at 10, available at http://yaleglobal.yale.edu/display.article?id=2016.
27. Adrian Lee, Medical Tourism: A Hot Destination, DAILY EXPRESS (London),
June 6, 2006, available at 2006 WLNR 9669509 (Westlaw).
28. Garud, supra note 4, at 318-19; Marcelo, supra note 26; see also Want that
Cardiac Surgery Done? Go to India!, INDIA ABROAD (N.Y. Ed.), June 24, 2005, at A40,
available at 2005 WLNR 12004858 (Westlaw).

426

WESTERN NEW ENGLAND LAW REVIEW

[Vol. 29:421

tively promotes its "International Patient Services."29 Apoll030 and
Escorts Heart Institute and Research Centre,31 another major In
dian tourist destination, even facilitate "virtual patient visits" for
family members who are unable to physically accompany patients.
Apollo reportedly treated 60,000 medical tourists between 2001 and
the spring of 2004. 32 This growing industry is supported by a num
ber of U.S.-based intermediaries such as IndUShealth33 and Planet
HospitaP4 that organize tourists' visits to India and other
destinations. 35
B.

Costs and Reimbursement

The medical procedures offered by providers in India and
other tourist destinations are considerably less expensive than in
Western countries such as the United States or the United King
dom. For example, in India, open-heart procedures cost about 10
percent of the average industrialized-country price. 36
Historically, procedures that attracted medical tourists were
those that were out-of-plan or otherwise would not be reimbursed
by the patient's insurer or funded by a national health service. To
day, there are some limited exceptions to this paradigm. Blue
Cross and Blue Shield (U.S.) and BUPA (U.K.) now reimburse for
29. Apollo Hosps. Group, Overview, http://apollohospitals.comJoverview.asp?
Pgeuld=1066 (last visited Mar, 18, 2007); Apollo Hosps. Group, International Patients,
http://www.apollohospitalgroup.comllnternational.htm (last visited Mar. 18, 2007); see
also Medilux Healthcare Ltd., The Apollo Hospitals Group, Guide for Patients and
their Doctors, available at http://www.mediluxhealth.netlpages/mediluxapollo.htm
(follow the "Introductory Brochure" hyperlink under the heading "Downloads," at the
bottom of the page) (last visited Mar. 18,2007); Superbrand 2003-2005, Apollo Hosps.
Group, http://www.superbrandsindia.com/superbrands2003/apollo-hospitals/index.htm
(last visited Mar. 18, 2007) (discussing the history of the Apollo Hospitals Group).
30. Apollo Hosps. Group, Virtual Patient Visit, http://www.apollohospitals.comJ
VirtuaIPatient.asp?Pgeuld=1066 (last visited Mar. 18, 2007).
31. See generally Escorts Heart lust. & Research Centre Limited, International
Patients, http://www.ehirc.comJinternational_patients/index.asp (last visited Mar. 18,
2007).
32. Medical Tourism, supra note 18; see also Jay Soloman, Traveling Cure: India's
New Coup in Outsourcing, WALL STREET J., Apr. 26, 2004, at AI, available at LEXIS.
33. IndUShealth, A New World of Care, http://www.indushealth.com (last visited
Mar. 18, 2007).
34. Planet Hosp., Medical Tourism World Wide, http://www.planethospital.com
(last visited Mar. 18, 2007).
35. Kher, supra note 21, at 46-47.
36. See Garud, supra note 4, at 319. See generally The Globalization of Health
Care: Can Medical Tourism Reduce Health Care Costs?: Hearing Before the S. Spec.
Comm. on Aging, 109th Congo (June 27, 2006), available at http://aging.senate.gov/
hearin~detail.cfm?id=270728&.
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treatments at some facilities in India.37 The same is also true of
some of the new "mini-medical," low-cost, limited-benefit plans
that increasingly attract U.S. consumers unable to afford traditional
health insurance. 38
Medical tourism has even appeared on the radar of govern
ment-funded health care as states seek to reduce their health care
costs. For example, a bill introduced in the West Virginia House of
Delegates in 2006 would have allowed employees covered by the
state's Public Employees Insurance Agency to use Joint Commis
sion International (JCI) accredited foreign hospitals, receive travel
reimbursement for themselves and a companion, and participate in
the savings with a cash rebate. 39
A different set of financing problems arises when the medical
tourist looks to the destination country to fund his or her health
care. The U.K. government has acknowledged that it "ha[s] never
required the [N]ational [H]ealth [S]ervice to provide statistics on
the number or nationality of overseas visitors treated" by the Na
tional Health Service,40 or the costs involved in providing this treat
ment (with cost estimates ranging from almost negligible sums to
£200 million per year).41 The government has a website devoted to
the issue,42 and has recently tightened its criteria for free care. 43
The first case of health tourism prosecuted by the National Health
Service Counter Fraud Service was settled when an Egyptian busi
nessman who had traveled to London specifically to get "free" Na
tional Health Service treatment agreed to pay the £30,000 COSt.44
37. Marcelo, supra note 26.
38. Kher, supra note 21, at 46-47. Reducing costs with medical tourism has also
been noted by employers. See Rick Martinez, A Passage to India for Surgery, NEWS &
OBSERVER (Raleigh, N.C.), June 21, 2006, at A17, available at 2006 WLNR 10683034
(Westlaw).
39. H.B. 4359, 77th Leg., 2d Sess. (W. Va. 2006), available at http://www.legis.
state.wv.uslBill_Text_HTMU2006_SESSIONS/RSlBillslhb4359%20intr.htm.
40. 436 PARL. DEB., H.C. (6th ser.) (2005) 2745W (statement of Jane Kennedy,
Sec'y of State for Health), available at http://www.publications.parliament.uk/palcm200
506/cmhansrd/cm050912/text/50912127.h tm.
41. See Are Health Tourists Draining the NHS?, BBC NEWS, May 14, 2004, http://
news.bbc.co.uk/2lhilhealth/3356255.stm.
42. See The Dep't of Health (U.K.), Overseas Visitors, http://www.dh.gov.uk/
PolicyAndGuidance/lntemationaUOverseasVisitors/fs/en (last visited Mar. 18, 2007).
43. National Health Service, 2004, S.1. 2004/614, art. 2,
1-3 (U.K.), available at
http://www.opsi.gov.uk/si/si2004/20040614.htm (amending National Health Service,
1989 S.1. 1989/306, art. 1, 'II 2 (U.K.)).
44. Health 'Tourist' Pays NHS £30,000, BBC NEWS, Apr. 6, 2005, http://news.bbc.
co. ukl2lhilhealth/4415491.stm.
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In the United States, the costs expended on patients who are

undocumented aliens have become part of the immigration debate.
The Emergency Medical Treatment and Active Labor Act (EM
TALA) requires medical screening (effectively requiring free emer
gency medical care), regardless of immigration or residency
status. 45 Some state legislation46 and common law tort duties 47
have similar effects. Federal legislators recently have engaged on
the issue. Thus, the Medicare Prescription Drug, Improvement,
and Modernization Act of 2003 (MMA)48 provides for reimburse
ment of emergency health services furnished to undocumented
aliens, resulting in large federal payments to border states. 49 In
contrast to such largesse, as of July 1, 2006, the Deficit Reduction
Act of 2005 requires individuals to provide satisfactory evidence of
citizenship or nationality when initially applying for Medicaid or
upon a recipient's first Medicaid re-determination. 50 Approxi
mately fifty million low-income people are currently on Medicaid.
Historically, self-attestation was sufficient. However, the new rules
require more stringent documentation. 51 California recently
delayed implementation of the new requirement pending final fed
eral guidance, risking the loss of federal funding. 52 Also, the Pov
45. Emergency Medical Treatment and Active Labor Act, 42 U.S.c. § 1395dd
(Supp. 2003).
46. See, e.g., Guerrero v. Copper Queen Hosp., 537 P.2d 1329, 1331-32 (Ariz.
1975).
47. See, e.g., Wilmington Gen. Hosp. v. Manlove, 174 A.2d 135, 139-40 (Del.
1961). But see, e.g., Guerrero, 537 P.2d at 1330-40 ("A private hospital has no duty to
accept a patient ... unless a different public policy has been declared by statute or
otherwise. ").
48. Medicare Prescription Drug, Improvement, and Modernization Act of 2003
(MMA), Pub. L. No. 108-173, § 1011, 117 Stat. 2066, 2432 (codified at 42 U.S.c.
§ 1395dd); see also Dep't of Health & Human Servs., Ctrs. for Medicare & Medicaid
Servs., Section 101 Provider Payment Determination, available at http://www.cms.hhs.
gov/CMSforms/downloads/cms10130a.pdf.
49. See generally Robert Pear, Payments to Help Hospitals Care for Illegal Immi
grants, N.Y. TIMES, May 10, 2005, at All, available at 2005 WLNR 7325694 (Westlaw)
(reporting payments of $70.8 million to California, $46 million to Texas, and $45 million
to Arizona).
50. Deficit Reduction Act of 2005, Pub. L. No. 109-171, § 6036, 120 Stat. 4 (codi
fied at 42 c.F.R. § 435.407(j».
51. See Letter from Dennis G. Smith, Dir., Ctrs. for Medicaid & State Opera
tions, to State Medicaid Directors (June 9, 2006), available at http://www.cms.hhs.gov/
smdUdownloads/SMD06012.pdf. See generally Robert Pear, Medicaid Rules Get
Tougher About Proof of Citizenship, N.Y. TIMES, June 5, 2006, at A4, available at 2006
WLNR 9593565 (Westlaw).
52. Rong-Gong Lin, II, State to Delay Benefit Rule: U.S. Law Set to Take Effect
July 1 Requires Proofof Citizenship for Medi-Cali Coverage, Officials Fear Hasty Action
Could Bar Legitimate Enrollees, L.A. TIMES, June 7, 2006, at B1, available at 2006
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erty Law Center has filed a class-action lawsuit challenging the new
procedures as violating both the Medicaid Act and due process
protections.53
As countries increase limitations on the provision of health
care to nonresidents, medical professionals are placed in ethical
jeopardy when a patient in need of care presents. For example, in
the United Kingdom, apparent prohibitions to the provision of free
medical care to asylum seekers have raised ethical questions. 54 It is
unclear the extent to which health care workers are responsible for
investigating the immigration status of patients before treating
them. 55 Similarly, those who staff emergency rooms in U.S. border
state hospitals increasingly find themselves drawn into the docu
mentation morass as pressure grows to ask the "immigration
question. "56
C.

Interstate Tourism

With geographically diverse major medical centers, and health
care rationed by personal resources or managed care organizations
rather than governmental policies, interstate medical tourism has
not been a noticeable phenomenon in the United States. Emergen
cies aside, patients typically seek treatment where they live and
only occasionally travel to specialized providers in other states. Al
though major medical centers do seek to attract patients from
outside their own region or networks and routinely offer travel and
accommodation services,57 these initiatives have not raised any subWLNR 9721607 (Westlaw); see also Rong-Gong Lin, II, Tighter Medicaid Rules Put on
Hold: A Federal Law Requires States to Now Verify Applicants' Citizenship, But Califor
nia and Others Are Taking It Slow, L.A. TIMES, Nov. 17,2006, at B1, available at 2006
WLNR 19953795 (Westlaw).
53. Press Release, Sargent Shriver Nat'l Ctr. on Poverty Law, Suit Challenges
New Law Requiring 50 Million People in Medicaid to Document Citizenship (June 28,
2006) (on file with Western New England Law Review). Subsequently, a preliminary
ruling was made against the plaintiffs on standing grounds. Bell v. Leavitt, No. 06 CV
3520, 2007 U.S. Dist. LEXIS 11675 (N.D. Ill. Feb. 16, 2006).
54. See, e.g., Edwin Borman, Health Tourism, 328 BRIT. MED. J. 60, 60-61 (2004),
available at http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=314036&blobtype=
pdf.
55. See, e.g., Adrian O'Dowd, Health Tourism: The Dilemma for Nurses, NURS.
ING TIMES, Nov. 4, 2003, at 32, 32-34, available at 2003 WLNR 10951050 (Westlaw).
56. Julia Preston, Texas Hospitals' Separate Paths Reflect the Debate on Immigra
tion, N.Y. TIMES, July 18, 2006, at AI, available at 2006 WLNR 12327709 (Westlaw)
(quoting Leticia Martinez, a patient at Parkland Memorial in Dallas, Texas).
57. See, e.g., Johns Hopkins Medicine, Hopkins USA, For Patients, http://www.
hopkinsusa.orgIUSAIPatients/default.asp (last visited Mar. 18, 2007); Univ. of Tex.,
M.D. Anderson Cancer Ctr., International Center, http://www.mdanderson.org/
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stantiallegal or ethical concerns. Such major providers are likely to
use a bricks-and-mortar franchising model and thus have a physical
referral presence in other states.58
Of growing interest, however, are online second-opinion ser
vices, such as The Cleveland Clinic's Remote Medical Second
Opinion service,59 which offer Internet-based consultations and po
tentially will attract out-of-state patients to their bricks-and-mortar
services. The Cleveland Clinic's service seeks to abide by state li
censure laws and specifically exc1udes60 the provision of services in
states that have highly restrictive rules as to online consultations. 61
Second-opinion sites lack most of the vices seen in the online medi
cal and prescribing services targeted by professional organizations,
regulators, and prosecutors. 62 They do share some of the opportu
nistic characteristics of so-called "questionnaire" prescribing In
ternet sites (where a prior relationship with the consulting physician
is unlikely)63 and tend to rely on record review rather than physical
examination (a common complaint about online "pill-mills").64
However, second-opinion "services tend not to get involved in pre
scribing, and their record review process furthers continuity of care
by involving, or at least copying their opinions to, the patient's ex
departments/IPC (follow the "Patient Services" hyperlink, then the "Patient Travel Ser
vice" hyperlink) (last visited Mar. 18, 2007).
58. Thomas R. McLean, The Offshoring of American Medicine: Scope, Economic
Issues and Legal Liabilities, 14 ANNALS HEALTH L. 205, 227 n.126 (2005); see, e.g.,
Mayo Clinic, Facts About Mayo Clinic in Arizona, http://www.mayoclinic.orgiabout/
arizona.html (last visited Mar. 18, 2007) (stating that Mayo Clinic Arizona offers ser
vices in at least sixty-five different medical and surgical disciplines); Mayo Clinic, Facts
About Mayo Clinic in Jacksonville, Florida, http://www.mayoclinic.orgiaboutl
jacksonville.html (last visited Mar. 18, 2007) (stating that Mayo Clinic Jacksonville has
over 306 physicians and over 4,378 allied health staff).
59. See generally Cleveland Clinic, Welcome to MyConsult, My Consult Services,
http://www.eclevelandclinic.orgimyConsuItHome (last visited Mar. 18, 2007); Partners
HealthCare System, Inc., Partners Online Specialty Consultations, https:l!econsults.
partners.org (last visited Mar. 18, 2007).
60. Cleveland Clinic, Remote Medical Second Opinion Frequently Asked
Questions, www.eclevelandclinic.orgiproductHome.jsp?productId=standard (follow the
"View Remote Medical Second Opinion Frequently Asked Questions" hyperlink, then
the "Is the eCleveland Clinic MyConsult remote second opinion service available in
every state?" hyperlink) (last visited Mar. 18, 2007).
61. See, e.g., OR. REV. STAT. ANN. §§ 677.135, 677.137 (West 2006).
62. See Nicolas P. Terry, Prescriptions sans Frontieres (or How I Stopped Worry
ing about Viagra on the Web but Grew Concerned about the Future of Healthcare Deliv
ery), 4 YALE J. HEALTH POL'y L. & ETHICS 183, 258-59 (2004) [hereinafter Terry,
Prescriptions sans Frontieres].
63. /d. at 259.
64. Id.; see infra text accompanying note 194.
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isting physician."65 Arguably, physical examination of "the patient
is less important in second opinion consultation cases, where most
of the analysis flows from review of blood work, scans, and pathol
ogy tests" and focuses on treatment options rather than initial
diagnosis. 66
International travel to avoid legal restrictions on types of
health care is relatively rare, although not unknown as, for exam
ple, in the case of foreign parents leveraging unregulated embryo
gender identification in the United States. 67 However, a number of
medical tourists do travel or seek to travel outside their own states
to benefit from more favorable socio-medical policies governing
death and dying. Recall, for example, the well-known Busalacchi
case. 68 Christine Busalacchi was an accident victim who had en
tered a permanent vegetative state. Her father and guardian
wished to move her from a Missouri rehabilitation center to a Min
nesota facility. Missouri sought to block her transfer in part be
cause of a suspicion that her guardian was attempting to leverage
the allegedly less stringent requirements in Minnesota for removal
of feeding tubes. The Missouri Court of Appeals remanded the
case to the trial court for further evidentiary hearings on the guard
ian's burden "to provide a reasonable basis for the need to move
Christine to another jurisdiction other than a desire to avoid the
laws of Missouri."69 The majority opinion stated, "[W]e will not
permit [the] guardian to forum shop in an effort to control whether
Christine lives or dies."70 However, Judge Smith, dissenting,
pointed out that, "Minnesota is not a medical or ethical waste
land. . . . There is a parochial arrogance in suggesting, as the State
does, that only in Missouri can Christine's medical, physical and le
gal well being be protected or that only here will her best interests
be considered."71
65. Terry, Prescriptions sans Frontieres, supra note 62, at 259; see, e.g., Daniel
Costello, Virtual Second Opinions, L.A. TIMES, Dec. 30, 2002, at F1, available at 2002
WLNR 12412963 (Westlaw).
66. Terry, Prescriptions sans Frontieres, supra note 62, at 259; see, e.g., Tara
Parker-Pope, Virtual Second Opinions: When the Web Can Be Better than Seeing a Local
Doc, WALL ST. J., Aug. 12, 2003, at D1, available at LEXIS.
67. Carla K. Johnson, u.s. Sex-Selection Clinics Attract Foreigners, SEATTLE
TIMES, June 15, 2006, at A18, available at 2006 WLNR 10391157 (Westlaw).
68. In re Busalacchi, No. 59852, 1991 WL 26851 (Mo. Ct. App. Mar. 5, 1991), later
proceedings at No. 73677, 1991 Mo. LEXIS 107 (Mo. Oct. 16, 1991).
69. Id. at *5.
70. Id. at *5, *9-10.
71. [d. at *10.
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Similar issues intrude into the assisted-suicide debate. Switzer
land and the Netherlands have less restrictive laws than other Euro
pean states or the United States. 72 Swiss law only makes assisting
suicide illegal when there is "self-interested motivation."73 Since
1998, Dignitas,74 a Swiss non-profit relying on its avowed policy of
"altruism," has reportedly provided accommodations and the nec
essary life-ending barbiturates for more than 450 European sick or
elderly "tourists" who have traveled to Switzerland to end their
lives.7 5 In spite of concerns voiced (and even criminal investiga
tions by police)76 in the deceased's countries of origin,77 Swiss legis
lators have refused to revisit their law.78
Oregon's Death with Dignity Act (ODWDA)79 is the only U.S.
analog to these more liberal and potentially tourist-attracting re
gimes. 80 ODWDA "exempts from civil or criminal liability state
licensed physicians who, in compliance with the specific safeguards
in [the statute], dispense or prescribe a lethal dose of drugs upon
the request of a terminally ill patient."81 In Gonzales v. Oregon,82
the United States Supreme Court rebuffed an attempt by the U.S.
Attorney General to use an interpretation of the federal Controlled
72. Switzerland, unlike the Netherlands, is not a member of the European Union.
See European Union, External Relations, EU's Relations with Switzerland, http://ec.
europa.eu/commlexternal_relations/switzerland/intro/index.htm (last visited Mar. 18,
2007). However, the "interstate" description used herein is appropriate given the coun
try's close relationship with the Union and the bilateral treaties between the parties that
provide for, e.g., freedom of movement of persons. See generally id.
73. Dignitas: Swiss Suicide Helpers-"Live with Dignity, Die with Dignity" Is the
Slogan of the Swiss Charity, BBC NEWS, Apr. 15, 2003, http://news.bbc.co.uk/2lhi/
healthl2948665.stm [hereinafter Dignitas: Swiss Suicide Helpers].
74. Dignitas, http://www.dignitas.ch (last visited Mar. 18, 2007).
75. See generally Dignitas: Swiss Suicide Helpers, supra note 73; Dignitas: Swiss
Suicide Helpers: Swiss Charity Dignitas Has Gained a Worldwide Reputation for Helping
People with Chronic Diseases to End Their Lives, BBC NEWS, Jan. 24 2006, http://news.
bbc.co.uk/2lhi/health/4643196.stm.
76. See, e.g., Death Quiz For Family, MIRROR (London), June 3, 2006, at 15, avail
able at 2006 WLNR 9510879 (Westlaw).
77. See, e.g., In re Z (2004) EWHC 2817, [2005]1 W.L.R. 959, 2004 WL 2790666
(Fam.) (U.K.) (refusing to order an injunction to restrain a competent person from
traveling from England to Switzerland for assisted suicide).
78. Hilary White, Switzerland Refuses to Alter Assisted Suicide Law to Nix Death
Tourism, LIFESITENEWS.COM, June 2, 2006, http://www.lifesite.netlldnl2006/junl0606
021O.html.
79. OR. REV. STAT. §§ 127.800-127.995 (2005).
80. California recently rejected similar legislation. Greg Lucas, Bill to Allow As
sisted Suicide is Rejected: State Senate Committee Head Casts Key Vote Against Measure,
S.F. CHRON., June 28, 2006, at AI, available at 2006 WLNR 11178674 (Westlaw).
81. Gonzales v. Oregon, 126 S. Ct. 904, 911 (2006).
82. Id.
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Substances Act (CSA)83 to frustrate ODWDA.84 Unlike the Swiss
assisted-suicide law, ODWDA specifically discourages medical
tourism by requiring Oregon residency.85 Critics argue, however,
that in practice, the residency determination is delegated to doctors
and that it fails to pose a major barrier to nonresidents. 86
Any interstate assisted-suicide debate is likely to pale in com
parison with the future legal landscape relating to abortion. Not
withstanding the controversies that Roe v. Wade 87 and its progeny
sparked, these decisions essentially provided a national ceiling on
legal disincentives to pregnancy terminations, and as a result,
should have reduced abortion-related tourism. However, this state
of affairs would change rapidly if the Supreme Court takes the bait
offered by a highly restricive state abortion statute 88 and reverses
Roe, particularly as some states will have passed "trigger laws" ban
ning abortion upon Roe's demise. 89
Of course, federally guaranteed legal equivalence does not al
ways create access to in-state health care. For example, South Da
kota has only one abortion provider, a Planned Parenthood clinic
staffed only once a week by doctors who travel from Minnesota. 9o
Mississippi and North Dakota have similar restrictive access is
83. Controlled Substances Act, 21 U.S.c. §§ 801-904 (2000).
84. Gonzales, 126 S. Ct. at 922-26. In contrast, a state ban on physician-assisted
suicide has been held by the Court not to violate the Due Process Clause of the Four
teenth Amendment. Washington v. Glucksberg, 521 U.S. 702, 734 (1997).
85. OR. REV. STAT. § 127.805 (2005). A person may establish residency in Ore
gon in the following ways:
(1) Possession of an Oregon driver license;
(2) Registration to vote in Oregon;
(3) Evidence that the person owns or leases property in Oregon; or
(4) Filing of an Oregon tax return for the most recent tax year.
Id. § 127.860.
86. See, e.g., The Consequences of Legalized Assisted Suicide and Euthanasia:
Hearing Before the Subcomm. on the Constitution, Civil Rights and Property Rights of
the S. Comm. on the Judiciary, 109th Congo (2006) (testimony of Rita L. Marker, Execu
tive Dir., Int'! Task Force on Euthanasia and Assisted Suicide), available at http://
judiciary.senate.gov/testimony.cfm?id=1916&wiUd5377.
87. Roe V. Wade, 410 U.S. 113 (1973).
88. This was the apparent intent behind the South Dakota statute, H.B. 1215,
2006 Leg., 81st Sess. (S.D. 2006)-however, the legislation was reversed by referendum.
See, e.g., Stephanie Simon, South Dakota Scraps Abortion Ban, L.A. TIMES, Nov. 8,
2006, at 16, available at 2006 WLNR 19353648 (Westlaw).
89. Judy Peres, States Set Stage for Bans on Abortion, CHI. TRIB., June 12, 2006, at
1, available at 2006 WLNR 10012408 (Westlaw).
90. Evelyn Nieves, S.D. Abortion Bill Takes Aim at 'Roe', WASH. POST, Feb. 24,
2006, at AI, available at 2006 WLNR 3182657 (Westlaw).
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sues,91 suggesting that many patients are, in fact, forced to travel
outside their own states for constitutionally protected medical
treatment.
Differences already exist between abortion laws across the fifty
states. For example, twenty-six states require some form of paren
tal consent or court authorization before a minor can terminate a
pregnancy,92 suggesting an incentive for at-risk minors to travel out
of state, and attracting controversial federal proposals to criminal
ize those who transport such tourists or doctors who circumvent
out-of-state barriers. 93 If Roe is overturned, the vector between re
strictive and unrestrictive states is likely to grow, creating a picture
of legal and ethical confusion that will exceed even that in Austra
lia, where diverse state laws,94 albeit generally liberal ones, create
uncertainty for doctors and lawyers. 95
In a possible post-Roe world, the United States could also find
itself visiting painful issues reminiscent of those experienced in the
Republic of Ireland following its constitutional amendment banning
abortions. 96 There the temperature of the debate escalated follow
ing successful legal challenges against restrictions on travel by wo
men seeking abortions abroad. 97 Roe's companion case, Doe v.
Boiton,98 invalidated residency requirements in a Georgia abortion
statute on the basis of the Privileges and Immunities Clause 99 be
cause a "contrary holding would mean that a State could limit to its

/d.
92. Crn. FOR REPROD. RTS., THE TEEN ENDANGERMENT Acr (H.R. 748; S.8,
396,403): HARMING YOUNG WOMEN WHO SEEK ABORTIONS (2006), available at http://
www.crlp.org/pub_fac_ccpa.html.
93. See, e.g., Child Custody Protection Act, S. 403, 109th Congo (2006).
94. See Natasha Cica, Abortion Law in Australia, in 1998-99 AUSTRALIAN PAR.
LIAMENTARY LIBRARY 1, available at http://www.aph.gov.au/library/pubs/rp/1998-99/99
rp01.htm (describing the abortion laws of each Australian state and territory).
95. See, e.g., Lachlan J de Crespigny & Julian Savulescu, Abortion: Time to Clar
ify Australia's Confusing Laws, 181 MED. J. AUSTL. 201, 201-03 (2004), available at
http://www.mja.com.au/pubJidissues/181_04_160804/dec10242_fm.pdf.
96. Eighth Amendment of the Constitution Act, 1983 (Amend. No. 8/1983) (Ir.),
available at http://www.irishstatutebook.ie/front.html (follow the "Acts of the
Oreachtas" hyperlink, then the "1983" hyperlink, then the "Amendment No 811983
Eighth Amendment of the Constitution Act, 1983" hyperlink) (last visited Mar. 18,
2007).
97. See, e.g., Att'y Gen. v. X [1992]1 LR. 1, 11 (Ir.); A. v. E. Health Bd., [1998]1
LR. 464, 473 (Ir.), available at http://www.bailii.orglie/cases/IEHCI1997/176.html.
98. Doe v. Bolton, 410 U.S. 179 (1973).
99. U.S. CONST. art. IV, § 2, cl. 1.
91.
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own residents the general medical care available within its bor
ders. "100 Justice Douglas famously wrote,
Freedom of movement across frontiers in either direction, and
inside frontiers as welI, was a part of our heritage. . . . It may be
as close to the heart of the individual as the choice of what he
eats, or wears, or reads. Freedom of movement is basic in our
scheme of values. 101
Any state that tries to prevent its own residents from traveling to a
more liberal abortion state will have to deal with that sentiment,
along with a host of federal constitutional impediments, although C.
Steven Bradford has argued that the issue is more nuanced than it
might appear at first sight.102
Such ethically complex and highly politicized issues aside, most
interstate tourism tends to be a function of differing reimbursement
rules or related state policies. In this area, European courts have
faced some of the most challenging issues. Citizens of member
states enjoy extensive freedom of movement within the European
Union. For example, Council Directive 2004/58,103 which became
100. Doe, 410 U.S. at 200.
101. Kent v. Dulles, 357 U.S. 116, 126 (1958). See also Bigelow v. Virginia, 421
U.S. 809 (1975), in which the Court held a Virginia statute, which was applied against a
publisher who carried an advertisement for lawful abortion services available in New
York, infringed his First Amendment rights. The majority opinion, authored by Justice
Blackmun, contained the following dicta:
The Virginia Legislature could not have regulated the advertiser's activity in
New York, and obviously could not have proscribed the activity in that State.
Neither could Virginia prevent its residents from traveling to New York to
obtain those services or, as the State conceded, prosecute them for going
there. Virginia possessed no authority to regulate the services provided in
New York-the skills and credentials of the New York physicians and of the
New York professionals who assisted them, the standards of the New York
hospitals and clinics to which patients were referred, or the practices and
charges of the New York referral services.
Id. at 822-24 (citations omitted).
102. See C. Steven Bradford, What Happens if Roe is Overruled? Extraterritorial
Regulation of Abortion by the States, 35 ARIZ. L. REV. 87, 170 (1993) ("[T]he intuitive
reaction against the extraterritorial application of abortion laws is not wholly justified
by the case law."); cf Seth F. Kreimer, The Law of Choice and Choice of Law: Abor
tion, the Right to Travel, and Extraterritorial Regulation in American Federalism, 67
N.Y.U. L. REV. 451, 519 (1992) ("The right to travel to more hospitable environs could
not, after the fourteenth amendment, be denied to former slaves seeking a better life.
Under the same principles, even if Roe continues to erode or is ultimately overruled,
that right cannot be denied to women seeking to choose their future.").
103. Council Directive 2004/58/EC of 29 Apr. 2004 on the Right of Citizens of the
Union and Their Family Members to Move and Reside Freely Within the Territory of
the Member States, 2004 O.J. (L 229) 35 (EC), available at http://eur-lex.europa.eu/
LexUriServlsite/en/oj/2004/1_229/'-2292004062gen00350048.pdf; see also Council Direc
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effective in April 2006, overhauled the existing patchwork of fed
eral European laws (including the case law of the European Court
of Justice)104 that permitted, for example, freedom of movement of
workers and tourists. Under the new Directive, a citizen (and, in
most cases, dependents and partners of a citizen) of a Union mem
ber state has an almost unfettered right to reside in another mem
ber state for three months.1 05 Thereafter, the person must be a
worker (or self-employed) or have sufficient resources not to be
come a burden on the social security system of the host state and
have comprehensive health insurance.1 06 After five years this status
converts into a right of permanent residence. 107 Host states have
only very limited rights to restrict freedom of movement based on
public health grounds. lOS Strong safeguards for equal protection in,
for example, access to employment or education, accompany the
rights of residency.1 09
The EU treaty severely limits federal control over the health
systems of member states.1 10 However, the European Court of Jus
tice (ECJ) has taken the position that state health systems cannot
act so as to impede federally mandated freedom of movement of
persons and services. All EU countries have universal coverage
funded either by direct taxation or compulsory social insurance.
However, they also have their own cost-containment policies, in
cluding forms of rationing. In a series of cases dealing with outpa
tient care and prescription fulfillment, the ECJ has refused to allow

tive 2004/38IEC of 29 Apr. 2004 on the Right of Citizens of the Union and Their Family
Members to Move and Reside Freely Within the Territory of the Member States, 2004
0.1. (L 158) 77 (EC), available at http://www.lex.unict.itleurolabor/enldocumentation/
dirapprova te/dir(04 )-38en. pdf.
104. See generally luliane Kokott, EU Citizenship-citoyens sans frontieres?, An
nual European Law Lecture at the Durham European Law Institute (2005) (transcript
available at http://www.dur.ac.uk/resources/deli/annualiecture/2005_DELI_Lecture.
pdf).
105. Council Directive 2004158, supra note 103, art. 6.
106. Id. art. 7.
107. Id. arts. 16-20.
108. Id. art. 29.
109. [d. art. 24.
110. "Community action in the field of public health shall fully respect the re
sponsibilities of the Member States for the organisation and delivery of health services
and medical care." EUROPEAN COMM'N, THE INTERNATIONAL MARKET AND HEALTH
SERVICES, REPORT OF THE HIGH LEVEL COMMITTEE ON HEALTH 5 (2001), available at
http://ec.europa.eulhealth/ph_overviewlDocuments/key063n.pdf.
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states to require prior authorization as a condition for reimbursing
medical costs incurred in another member state. III
The court has been somewhat more circumspect regarding im
pediments to inpatient care provided elsewhere in the EU, permit
ting requirements of prior authorization when the member state
can provide the care without "undue delay."112 However, this qual
ification must now be read subject to the recent Watts case. 113 A
75-year-old arthritic patient who had been wait-listed in England
for hip replacement surgery, Mrs. Watts applied under the U.K.'s
version of the EU's existing medical tourism rules, the so-called
E112 scheme,114 but her application was refused. Subsequently,
Mrs. Watts paid £3900 to have the procedure performed in France
and then sought reimbursement from the National Health Service,
which was refused. The EeJ interpreted EU treaty and legislative
provisions regarding freedom of movement of persons and medical
services to hold that:
A refusal to grant prior authorization cannot be based merely on
the existence of waiting lists intended to enable the supply of
hospital care to be planned and managed on the basis of prede
termined general clinical priorities, without carrying out in the
individual case in question an objective medical assessment of
the patient's medical condition, the history and probable course
of his illness, the degree of pain he is in and/or the nature of his
disability at the time when the request for authorization was
made or renewed. u5

As a result, EU health care systems will be forced to reimburse
medical tourists who face "undue delay" in their own countries in
light of their individual medical conditions, notwithstanding inter
111. See, e.g., Decker v. Caisse de Maladie des Employes Prives, Case C-120/95,
1998 E.c.R. 1-01831; Kohll v. Union des Caisses de Maladie, Case C-158/96, 1998
E.C.R. 1-01931, 2 C.M.L.R. 879 (1998); MUller-Faure v. Onderlinge Waarborgmaat
schappij OZ Zorgverzekeringen, Case C-385/99, 2003 E.C.R. 1-04509; Ludwig Leichtle
v. Bundesanstalt flir Arbeit, Case C-8/02, 2004 E.C.R. 1-02641, available at http://eur
lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:62002JO008:EN:HTML.
112. See Geracrts-Smits v. Stichting Ziekenfonds, Case C-157/99, 2001 E.C.R. 1
05473; Muller-Faure, Case C-385/99, 2003 E.c.R. 1-04509.
113. Watts v. Bedford Primary Care Trust, Case C-372/04, 2006 E.C.R. 1-04325,3
C.M.L.R. 5.
114. Dep't of Health (U.K.), Going to an EEA Country or Switzerland in Order
to Get Treatment, http://www.dh.gov.uk/en/Policyandguidance/Healthadvicefor
travellers/index.htm (follow the "Getting medical treatment around the world" hyper
link, then the "Getting treatment in EEA countries and Switzerland" hyperlink) (last
visited Mar. 18, 2007).
115. Watts, Case C-372/04, 2006 E.C.R. 1-04325, 3 C.M.L.R. 5.
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nal budgetary considerations. That reimbursement obligation may
also include travel costs if the state already pays for travel related to
intrastate treatment. 116 Major increases in medical tourism follow
ing Watts are likely to push EU states further along the road to a
pan-European health care system. 117

D. Virtual Tourism
For most Americans, the closest they will ever come to medical
tourism is the "virtual" tourism they will experience, often unknow
ingly, when they visit a foreign website offering medical informa
tion or advice. The "medical" content that appears on such sites
may be extremely valuable and may come from peer-reviewed
sources,118 but too many sites contain information that is inaccu
rate,119 dangerous,12o or contrary to accepted medical practice.121
Other than urging "surfer-beware" and promoting information
about high quality sites,122 there is little to be done to protect
American virtual tourists against the harm they might suffer from
relying on either domestic or foreign Web content. Formal ap
proaches to assuring Internet content quality assurance are fraught
with legal difficulties. "Public law intervention tends to be limited
to obviously dangerous health content where government agencies
can apply their traditional consumer-protection, drug-regulation,
and fraud powers."123 Attempts at using more robust public regula

n

116. Id.
138-43.
117. See, e.g., EU Chief Supports 'Health Market', BBC NEWS, Sept. 5, 2006,
http://news.bbc.co.ukl2Ihilhealthl5315700.stm (reporting EU health Commissioner Mar
kos Kyrianou's argument for single market in health care).
118. See, e.g., WebMD, About WebMD-Editorial Policy, http://www.webmd.
com/contentJarticie/60/67018.htm (last visited Mar. 18, 2007).
119. See, e.g., James D. Cooper & Henry M. Feder Jr., Inaccurate Information
About Lyme Disease on the Internet, 23 PEDIATRIC INFECTIOUS DISEASE J. 1105, 1107
(2004) (noting that, of nineteen websites relating to lyme disease, nine gave inaccurate
information concerning two or more topics).
120. See generally Claire W. Anderson, A Call for Internet Pharmacies to Comply
with Quality Standards, 12 QUALITY & SAFETY HEALTH CARE 86 (2003).
121. See, e.g., Robert M. Wolfe et aI., Content and Design Attributes of Antivac
cination Web Sites, 287 JAMA 3245, 3247-48 (2002).
122. Cf HealthRatings.org, Ratings of Health Web Sites, http://www.health
ratings.org (last visited Mar. 18, 2007).
123. Terry, Prescriptions sans Frontieres, supra note 62, at 242; see, e.g., Press Re
lease, FTC, FTC Charges Direct Marketers of Ephedra Weight Loss Products with
Making Deceptive Efficacy and Safety Claims (July 1, 2003), available at http://www.ftc.
gov/opa/2003/07 /ephedra.h tm.
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tion or private litigation (even assuming jurisdiction and enforce
ment) are likely to conflict with guarantees of free speech. 124
European institutions, including the European Commission, 125
are enamored of self-regulatory ratings systems and codes of con
duct 126 often identified by "trustmarks."127 However, on balance,
the "benefits to patients of self-regulatory codes are outweighed by
the risks of overconfidence generated by valid trustmarks or out
right fraud from the counterfeit ones."128
II.

OUTSOURCING

Medical tourism (say, a U.S. resident who travels to India for a
heart bypass) may be viewed as the complete outsourcing of health
care. 129 Traditionally, however, outsourcing has been viewed as the
domestic export of non-core (or non-core competency) ancillary
tasks.13° U.S. providers routinely use domestic outsourcing for non
clinical tasks, everything from food service and gift shops to laundry
and security. Today, some health care outsourcing is so well estab
lished that the service providers are recognized as distinct health
care entities; for example, "Pharmacy Benefits Managers" (PBMs)
that health plans or employers use to control pharmaceutical
costs.1 31 By 2005, one hundred U.S. health care providers (repre
senting 6 percent of hospitals and 10 percent of beds) had fully out
124. See generally Nicolas P. Terry, Cyber-Malpractice: Legal Exposure for
Cybermedicine, 25 AM. J.L. & MED. 327 (1999).
125. See, e.g., Europe's Information Soc'y Thematic Portal, Focusing on Quality,
http://europa.eu.int/information_society/activities/health/policy_action_plan/quality_
criteria/index_en.htm (last visited Mar. 18, 2007).
126. See, e.g., Internet Healthcare Coalition, eHealth Code of Ethics, http://www.
ihealthcoalition.orglethics/ehcode.html (last visited Mar. 18, 2007); WebMD, Inc., Our
Privacy Commitment to You, Health Internet Ethics, http://www.webmd.com!content/
pages/8/1761_50193.htm (last visited Mar. 18, 2007).
127. Trustmarks or quality marks are (frequently trademarked) labels or graphi
cal "marks" designed to signify compliance with criteria established by an independent
mark holder. See, e.g., Health on the Net Found., HON Code of Conduct (HONcode)
for Medical and Health Web Sites, The HONcode in Brief, http://www.hon.chIHON
code/Conduct.html (last visited Mar. 18, 2007).
128. Terry, Prescriptions sans Frontieres, note 62, at 243; see also Nicolas P. Terry,
A Transatlantic Perspective on Regulating Health Information, 324 BRIT. MED. 1. 602,
602-06 (2002); Nicolas P. Terry, Rating the "Raters": Legal Exposure of Trustmark Au
thorities in the Context of Consumer Health Informatics, 2 J. MED. INTERNET RES. e18
(2000), available at http://www.jmir.org/2000/3/e18.
129. See Paul Malik, Insourcing and Outsourcing, 20 CAN. J. CARDIOLOGY 679,
679 (2004), available at http://www.pulsus.com/CARDIOLl20_07/mali_ed.htm.
130. See, e.g., id.
131. See, e.g., Milt Freudenheim, Drugstores Fret as Insurers Demand Pills by
Mail, N.Y. TIMES, Jan. 1,2005, at AI, available at 2005 WLNR 22598 (Westlaw).
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sourced their information technologies (IT) functions. 132 Although
late to the outsourcing model (compared to, for example, financial
services), health care IT (HIT) outsourcing both within the U.S.
and offshore is increasing rapidly, and already includes managed
care call centers, systems design, and strategic planning. 133
As documented by Tom McLean, offshoring has a rich, com
plex socio-political history, and it was only a matter of time before
it caught health care services in its web.1 34 Non-domestic, offshore
outsourcing was first embraced by U.S. IT companies and it has
grown exponentially.B 5 IT outsourcing has permitted the leverag
ing of time zones to provide 24-7 support in addition to decreasing
labor costs by using highly trained, but less expensive, foreign work
ers for call centers. Not all foreign outsourcing goes to the Eastern
Hemisphere. So-called nearshoring refers to outsourcing to coun
tries that share geographic or cultural proximity with the source
country. Increasingly, European countries nearshore to former
Eastern bloc countries, while United States companies look to Ca
nada or Ireland.136
A.

Offshore Data Processing

Today, HIT are at the very core of health care. U.S. health
care's tardy137 but rapidly accelerating investment in HIT, including
HIPAA-mandated electronic transactions, error-reducing "process
132. The HIT Report from KLAS: Successes and Challenges with Full IT Out
sourcing, 4 ELEcrRONICHEALTHCARE 110, 110-16 (2005), available at http://www.long
woods.comlproduct.php?productid=I7707&cat=401&page=1 (follow the "Download
PDF" hyperlink).
133. See, e.g., Harry Downs, Jr., Outsourcing and IT: Keeping Innovation In
House, AHIP COVERAGE, Sept.-Oct. 2004, at 72; Susan Kirkpatrick, Using Information
Networks as a Decision-Making Tool, J. HEALTHCARE RESOURCE MGMT., Nov. 1995, at
21, 21-24; see also Alan Joch, Wiping the Slate Clean: Why Network Outsourcing is In,
HEALTHCARE INFORMATICS, Jan. 1998, 81, 81-84.
134. See generally McLean, supra note 58.
135. See, e.g., Saritha Rai, India Becoming a Crucial Cog in the Machine at I.B.M.,
N.Y. TIMES, June 5, 2006, at C4, available at 2006 WLNR 9593509 (WestIaw) (reporting
that IBM now has 43,000 employees in India, while continuing to make cuts in its U.S.
workforce); see also Steve Lohr, Indian Outsourcer Says Big Profits Will Continue, N.Y.
TIMES, Apr. 15, 2006, at C3, available at 2006 WLNR 6337512 (Westlaw) (reporting
positive revenue and profits for Indian and U.S. companies' outsourcing operations in
India).
136. Geoffrey Nairn, New Contenders Jostle for Software Crown, FIN. TIMES
(London), Dec. 1,2004, available at 2004 WLNR 12534333 (WestIaw).
137. See generally Jeff Goldsmith et aI., Federal Health Information Policy: A
Case of Arrested Development, HEALTH AFF., May-June 2003, at 44.
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supporting" technologies, and electronic medical records,138 has co
incided with unprecedented pressure to reduce costs. IT is not a
health care industry core competency and has proved itself to be a
prime candidate for offshoring. The administrative complexity and
costs of U.S. health care are significant contributors to its higher
prices relative to other countries. 139 HIPAA's "Administrative
Simplification" has not delivered on expected cost-savings;140 off
shoring its mandated electronic transactions processes to lower-cost
IT countries might.
In India, data entry costs are less than half of what they are in
the United States. 141 In fact, "Already half of the $20 billion U.S.
medical transcription industry is outsourced" to other countries.1 42
Billing, coding, data-clearing, claims processing, and electronic
records data processing and storage follow.
U.S. law extensively regulates the processing and storage of pa
tient data, such as medical records and images, with regard to reten
tion, integrity, confidentiality, and security. Although now
supplemented by federal Medicare rules,143 state statutory rules
generally continue to govern the length of time that providers must
retain records and images.1 44 In addition, the AMA Code of Medi
cal Ethics places an obligation on physicians "to retain patient
records which may reasonably be of value to a patient" and urges
physicians to take note of state and federal retention rules and ap
plicable medical malpractice statutes of limitation. 145 Similarly,
federal regulations,146 Joint Commission on Accreditation of
138. See generally Nicolas P. Terry, To HIPAA, a Son: Assessing the Technical,
Conceptual, and Legal Frameworks for Patient Safety Information, 12 WIDENER L. REV.
137 (2006) [hereinafter Terry, To HIPAA, a Son).
139. Uwe E. Reinhardt et aI., U.S. Health Care Spending in an International Con
text, HEALTH AFF., May-June 2004, at 10, 13-15.
140. D'Arcy Guerin Gue with Randa Upham, The HIPAA Prescription for
Healthcare-Why Isn't It Working?, HEALTH MGMT. TECH., Sept. 2004, at 34, 34, 36.
141. Ed Silverman, It's a Small World After All: Outsourcing Makes Inroads,
MANAGED CARE, June 2005, at 46, 48.
142. Terry, To HIPAA, a Son, supra note 138, at 164; see David Lazarus, Looking
Offshore: Outsourced UCSF Notes Highlight Privacy Risk, How One Offshore Worker
Sent Tremor Through Medical System, S.F. CHRON., Mar. 28, 2004, at Al [hereinafter
Lazarus, Looking Offshore), available at 2004 WLNR 7644456 (Westlaw).
143. See, e.g., Condition of Participation: Medical Record Services, 42 C.F.R.
§ 482.24(b)(1) (2005) ("Medical records must be retained in their original or legally
reproduced form for a period of at least 5 years. ").
144. See, e.g., N.M. STAT. ANN. § 14-6-2 (West 2003); LA. REV. STAT. ANN.
§ 40:2144(F) (2001).
145. CODE OF MEDICAL ETHICS E-7.05 (1994).
146. 42 C.F.R. §§ 482.24(b), (c) (2006).
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Healthcare Organizations (JCAHO) accreditation rules,147 and
state licensure laws all impose duties of accuracy, completeness, leg
ibility, and timeliness on the keeping of records.1 48 Some state stat
utes prohibit the alteration of records,149 and expanding common
law remedies for spoliation penalize their concealment or destruc
tion. 150 There is also authority for the proposition that keeping in
adequate records can constitute common-law malpractice.1 51 The
as yet unanswered question is how effective these domestic-facing
regulatory models are in protecting U.S. patient data processed
offshore.
Concerns about the confidentiality and security of patient data
being processed offshore were highlighted by two events in 2003.
First, a medical transcriber in Pakistan, working for a subcontractor
for the University of California at San Francisco, e-mailed the hos
pital and threatened to distribute patient files on the Internet after
the contractor allegedly failed to pay her. 152 Just a few weeks later,
employees of the Indian office of another U.S. transcription com
pany sent an anonymous e-mail to the company threatening to re

147. JOINT COMM'N ON ACCREDITATION OF HEALTHCARE ORGS., 2005 CRITICAL
ACCESS HOSPITAL STANDARDS, MANAGEMENT OF INFORMATION 14, available at http://
www.worh.orglpdCetc/Dec2/standards.pdf ("The medical record contains sufficient in
formation to identify the patient; support the diagnosis/condition; justify the care, treat
ment, and services; document the course and results of care, treatment, and services;
and promote continuity of care among providers.").
148. See, e.g., N.M. STAT. ANN. § 61-6-15(D) (West 2003) ('''Unprofessional or
dishonorable conduct' ... includes ... (33) improper management of medical records,
including failure to maintain timely, accurate, legible and complete medical records.");
NEV. REV. STAT. ANN. § 630.3062-1 (LexisNexis 2005); WYo. STAT. ANN. § 33-26
402(a)(xxvii)(G) (2005); Schwarz v. Bd. of Regents, 453 N.Y.S.2d 836 (N.Y. App. Div.
1982); Nieves v. Chassin, 625 N.Y.S.2d 344 (N.Y. App. Div. 1995).
149. See, e.g., NEV. REV. STAT. ANN. § 630.3062-2 (LexisNexis 2005).
150. See, e.g., Keene v. Brigham & Women's Hosp., Inc., 786 N.E.2d 824 (Mass.
2003) (upholding sanction of liability because of missing records); Rosenblit v. Zimmer
man, 766 A.2d 749 (N.J. 2000) (canvassing various remedies and adopting independent
tort remedy); cf Brown v. Hamid, 856 S.W.2d 51, 57 (Mo. 1993) ("The Missouri cases,
statutes, and common law address a physician's duty to let the patient inspect and copy
medical records. They do not create an independent duty to maintain medical records.
To be sure, in another case, failure to maintain medical records may contribute to, or
constitute, medical malpractice. . . . There is no need, in this case, to recognize an
independent tort of negligent maintenance of medical records.").
151. Thomas v. United States, 660 F. Supp. 216, 218 (D.C. Cir. 1987).
152. David Lazarus, A Tough Lesson on Medical Privacy, Pakistani Transcriber
Threatens UCSF Over Back Pay, S.F. CHRON., Oct. 22, 2003, at AI, available at 2003
WLNR 8302881 (Westlaw); see also Lazarus, Looking Offshore, supra note 142.
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lease medical records, but they were apprehended by police at a
Bangalore Internet cafe. 153
HIPAA privacy (actually, confidentiality)154 and security ap
plies only to a limited subset of health care entities,155 "a relatively
narrow purview given the range of U.S. and offshore players likely
to be involved in [medical data] processing."156 Notwithstanding,
many of the U.S.-based data "extenders," such as outsourced radi
ology or ICU monitors, likely will be "covered entities." Further
more, U.S. or offshore data processors of Protected Health
Information (PHI)157 are "business associates"158 of HIPAA "cov
ered entities."159 As such, these contractual relationships must in
corporate HIPAA limitations on data disclosure.1 6o
U.S. records laws and HIPAA confidentiality and security ob
viously apply to U.S. providers who use offshore data entry and
processing. 161 However, questions have been raised as to the extent
to which such protections can be enforced against non-U.S. contrac
tors.1 62 In 2004, Congressman Edward Markey formally questioned
the sufficiency of offshore data protection. Responding, "then
HHS Secretary [Tommy] Thompson admitted that his department
failed to document the 'nature or content' of the contracts between
covered entities and their business associates, or directly regulate
153. David Lazarus, Extortion Threat to Patients' Records, S.F. CHRON., Apr. 2,
2004, at A1, available at 2004 WLNR 7648210 (Westlaw).
154. See generally Nicolas P. Terry & Leslie P. Francis, Ensuring the Privacy and
Confidentiality of Electronic Health Records, 2007 U. ILL. L. REV. 681 [hereinafter
Terry & Francis, Ensuring the Privacy and Confidentiality of Electronic Health Records].
155. 45 C.F.R. § 160.103 (2005).
156. Terry, To HIPAA, a Son, supra note 138, at 164.
157. 45 C.F.R. § 160.103 (defining "protected health information" as "individu
ally identifiable health information," which includes "demographic information col
lected from an individual, and: (1) Is created or received by a health care provider,
health plan, employer, or health care clearinghouse; and (2) Relates to the past, pre
sent, or future physical or mental health or condition of an individual; the provision of
health care to an individual; or the past, present, or future payment for the provision of
health care to an individual; and (i) That identifies the individual; or (ii) With respect to
which there is a reasonable basis to believe the information can be used to identify the
individual ").
158. Terry, To HIPAA, a Son, supra note 138, at 164.
159. Id.
160. 45 C.F.R. § 164.504(c) (2005).
161. For a useful survey of the data confidentiality and security issues and detail
on legal reform in destination countries, see Barbara Crutchfield George & Deborah
Roach Gaut, Offshore Outsourcing to India by U.S. and E. U. Companies: Legal and
Cross-Cultural Issues That Affect Data Privacy Regulation In Business, 6 U.c. DAVIS
Bus. L.J. 13 (2006).
162. See, e.g., David Lazarus, Medical Charts Not All that Private, S.F. eHRON.,
June 8, 2003, at A1, available at 2003 WLNR 8241189 (Westlaw).
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offshore business associates."163 Keen to protect their new HIT in
dustries, offshore processing destinations such as India and Paki
stan are attempting to reduce the vector between domestic and
foreign data-source laws by improving legal protections for out
sourced data processed within their borders. 164
B.

Offshore Medical Services

Information technologies are obviously highly portable. But
other technology that enables portability affects the way clinical
services may be provided. Specifically, technology facilitates the
disaggregation (e.g., separating an assay from its interpretation)165
of some heretofore unitary and exclusively professional tasks. Dis
aggregation of professional tasks already has led to physician ex
tenders, such as nurse practitioners and physician assistants. The
technological mediation of health care enables data extenders.
Faced with growing shortages in some physician specialties,166 the
health care industry is leveraging this technology to outsource and
even offshore some clinical tasks to data extenders. Radiology is
already heavily offshored; pathology may soon follow, as may the
already outsourced task of ICU monitoring.1 67
The Leapfrog Group, the well-known health safety advocacy
organization, has noted that mortality rates are significantly lower
in hospital ICUs that are exclusively staffed with board-certified in
tensivists. 168 ICU demand is increasing dramatically, but at the
same time, there is a shortage of both intensivists and pharma
163. Terry, To HIPAA, a Son, supra note 138, at 165 (citing Letter from Tommy
G. Thompson, Sec'y, U.S. Dep't of Health & Human Servs., to Edward J. Markey,
Congressman, U.S. H. of Reps. 2 (June 14, 2004».
164. See, e.g., IT Ministry Unveils Draft of Data Protection Act, DAILY TIMES
(Pakistan), Nov.14, 2004, available at http://www.dailytimes.com.pk/default.asp?page=
story_14-11-2004_pg7 _38.
165. Robert M. Wachter, The "Dis-location" of u.s. Medicine-The Implications
of Medical Outsourcing, 354 NEW ENG. J. MED. 661, 663 (2006).
166. See, e.g., Raja Mishra, Radiology Work Shifts To Overnight, Overseas, Bos
TON GLOBE, June 29, 2005, at AI, available at 2005 WLNR 10231496 (Westlaw) (noting
shortages in Massachusetts of neurosurgery, anesthesiology, gastroenterology, cardiol
ogy, orthopedics, and radiology specialists). See generally Richard A. Cooper et aI.,
Economic and Demographic Trends Signal an Impending Physician Shortage, HEALTH
AFF., Jan.-Feb. 2002, at 140, available at http://content.healthaffairs.orglcgi/reprintl21111
140.pdf.
167. Rob Stein, Hospital Services Performed Overseas, WASH. POST, Apr. 24,
2005, at AI, available at 2005 WLNR 6383494 (Westlaw).
168. THE LEAPFROG GROUP, ICU PHYSICIAN STAFFING 1 (2007), available at
http://www.leapfroggroup.orglmedia/file/Leapfrog-ICU _Ph ysician_Staffin~Fact_Sheet.
pdf.

2007]

MEDICAL TOURISM AND OUTSOURCING

445

cistS. 169 As a result, electronic outsourcing of ICU supervision170 is
now common, with more than one hundred U.S. hospitals using re
mote monitoring for their ICUSPl If reimbursement rules change,
remote monitoring by home health care agencies likely will follow
this trend. l72 There are no obvious practical reasons why such mon
itoring cannot take place on the other side of the world.
There is a critical shortage of radiologists practicing in the
United States, leading to some three hundred U.S. hospitals now
outsourcing their imaging. 173 This is possible because of the sophis
tication of modern Picture Archiving and Communication System
networks. Again, outsourcing is possible because of disaggregation
and, once disaggregated, there are few barriers to offshore process
ing. Licensed (frequently dual-licensed), American-trained, and
credentialed radiologists in Australia,174 Israel,175 and India all pro
vide nighttime coverage for U.S. hospitals. For example, Ban
galore-based Teleradiology Solutions uses HIPAA-compliant high
speed connections to provide a "preliminary interpretation" of CT,
MRI, conventional, and ultrasound scans within thirty minutes from
when the scan takes place in the United Statesp6 The term "pre
liminary interpretation" is used in large part because of the Centers
for Medicare and Medicaid Services rule that, some emergency situ
ations aside, Medicare does not reimburse for services furnished
outside the United States.1 77 As a result, a domestic radiologist will
(or should) submit a "final primary report" after subsequently ex
169. Leo Anthony Celi et aI., The eICU: It's Not Just Telemedicine, 29 CRITICAL
CARE MED. N183, N183-N184 (2001).
170. For a description of the technologies in practice, see Celi, id. See Carolyn
Thompson, 'EICU' Lets Doctors Monitor Many Patients, EWEEK, Jan. 3, 2005, available
at 2005 WLNR 1943649 (Westlaw); Timothy J. Mullaney, The Doctor is (Plugged) In,
Bus. WK., June 26, 2006, at 56, available at 2006 WLNR 10780096 (Westlaw).
171. Sarah Lovinger, Beaming Images Overseas Sparks Controversy at Home,
ACP OBSERVER, May 2006, available at http://www.acponline.orgljournals/news/may06/
outsource.htm.
172. See, e.g., Marilyn J. Field & Jim Grigsby, Telemedicine and Remote Patient
Monitoring, 288 JAMA 423, 424 (2002), available at http://jama.ama-assn.orglcgi/
reprint/288/4/423.pdf.

173. Lovinger, supra note 171.
174. Greg Gillespie, Down Under Image Readers Cover U.S. Radiologists,
HEALTH DATA MOMT., July 1, 2005, at 16, available at 2005 WLNR 10362694
(Westlaw).
175. Erica Chernofsky, The View from Here, JERUSALEM POST (Isr.), Mar. 17,
2006, at 22, available at 2006 WLNR 4799982 (Westlaw).
176. See, e.g., Teleradiology Solutions, Interpretive Services, http://www.telradsol.
com/services.htm (last visited Mar. 18, 2007).
177. 42 C.F.R. § 411.9(a) (2006). Centers for Medicare & Medicaid Services
(CMS) is currently reviewing aspects of this rule. Press Release, eMS, FY 2007 Hospi
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amining the image,l78 However, additional state impediments to
such arrangements, such as corporate practice and fee splitting, may
not be so simply avoided. 179
C.

Pharmaceutical Arbitrage

There are several motives behind patient interest in "outsourc
ing" access to pharmaceuticals. Worldwide, pharmaceutical compa
nies practice price and distribution discrimination;180 the limited
formularies of state-run health care systems and managed care or
ganizations, or their Pharmacy Benefits Managers (PBMs), bar sub
sidized access to some drugs, while underinsured patients (those
with shallow coverage) increasingly cannot afford the "market
price" of drugs prescribed for them. l81 Meanwhile, some outlying
"patients" pursue controlled substances or lifestyle drugs that their
doctors will not prescribe or that they are too embarrassed to
request. 182
As a general rule, health care consumers or payers in the
United States cannot legally acquire prescription drugs outside
traditional domestic distribution channels. 183 The FDA, citing the
Food, Drug, and Cosmetic Act (FDCA),184 has taken the position
that "gray-market" versions of an approved drug, and even U.S.
tal Inpatient Prospective Payment System Proposed Rule (Apr. 12, 2006), available at
http://www.cms.hhs.gov/apps/media/press/release.asp?Counter=1834.
178. Wachter, supra note 165, at 662.
179. See, e.g., Nicole Huberfeld, Be Not Afraid of Change: Time to Eliminate the
Corporate Practice of Medicine Doctrine, 14 HEALTH MATRIX 243, 243-44 (2004).
The modern version of the corporate practice of medicine doctrine derives
from two principles: (1) any person that "practices medicine" must be licensed
by the state in which she practices to provide medical services and (2) health
care professionals cannot assist unlicensed persons or entities in practicing un
licensed medicine, which prevents the splitting of professional fees with non
professionals.
Id. (citations omitted).
180. Cf In re Canadian Import Antitrust Litigation, 470 F.3d 785, 791 (8th Cir.
2006) ("The absence of competition from Canadian sources in the domestic prescription
drug market, therefore, is caused by the federal statutory and regulatory scheme
adopted by the United States government, not by the conduct of the defendants. Con
sequently, the alleged conduct of the defendants did not cause an injury of the type that
the antitrust laws were designed to remedy.").
181. See, e.g., Milt Freudenheim, Drug Prices Up Sharply This Year, N.Y. TIMES,
June 21, 2006, at C1, available at 2006 WLNR 10674943 (Westlaw) (discussing an
AARP study that noted that the wholesale price of brand-name pharmaceuticals in
creased 3.9 percent, four times the inflation rate during the first quarter of 2006).
182. See Terry, Prescriptions sans Frontieres, supra note 62, at 222, 225.
183. See generally id.
184. Food, Drug, & Cosmetic Act, 21 U.S.c. § 355(a) (2000).
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sourced reimported drugs, are unapproved because they do not
comply with U.S. labeling and packaging requirements 185 and con
travene the monopoly on reimportation granted to U.S.
manufacturers. 186
As is the case in most Western countries,187 an exception exists
for those who enter the United States (including returning medical
tourists) with personal supplies of prescription drugs. The Con
trolled Substances Act (CSA)188 allows individuals to personally
import a prescription drug "if: (1) the substance is found in one of
the approved 'schedules,' (2) the substance is in its original
container, (3) a declaration is made to the United States Customs
Service, and (4) use of such substance is permitted by federal and
state laws."189 "There is no personal importation exception in the
FDCA. The FDA, however, has issued enforcement guidelines [for
customs officers] that create a de facto exemption" where "'the
quantity and purpose are clearly for personal use, and the product
does not present an unreasonable risk to the user."'190 The CSA
exemption clearly assumes that the drugs are in the possession of a
traveler,191 while the FDA guidance implies the same by excluding
commercial and promotional shipments. "The Guidance also states
that non-commercial shipments generally include products that are:
'personally carried, shipped by a personal non-commercial repre
sentative of a co-signee, or shipped from [a] foreign medical center
185. See generally 21 C.F.R. § 314.50 (2006) (listing drug application
requirements).
186. 21 U.S.c. § 381(d)(1) ("[N]o drug subject to section 353(b) of this title ...
which is manufactured in a State and exported may be imported into the United States
unless the drug is imported by the manufacturer of the drug.").
187. See, e.g., Australian Gov., Therapeutic Goods Admin., Travellers Visiting
Australia, Importing Medicines for Personal Use, http://www.tga.gov.au/docs/htmllbring
med/intoaust.htm (last visited Mar. 18, 2007).
188. Controlled Substances Act, 21 U.S.c. §§ 801-971 (2000).
189. Terry, Prescriptions sans Frontieres, supra note 62, at 205 (citing 21 U.S.c.
§ 956(a) (2000». The Controlled Substances Trafficking Prohibition Act of 1998 tight
ened this exception, stating that a U.S. resident may not enter the United States
through an international land border with more than fifty dosage units of a controlled
substance unless the individual possesses a valid prescription issued by a practitioner in
accordance with federal and state law. See id. (citing 21 U.S.c. § 956(a)(2».
190. Terry, Prescriptions sans Frontieres, supra note 62, at 272 n.129 (quoting
FDA, OFF. OF REGULATORY AFF., REGULATORY PROCEDURES MANUAL: CHAPTER 9,
SUBCHAPER COVERAGE OF PERSONAL IMPORTATIONS (2006». Chapter 9 is currently
under revision.
191. 21 C.F.R. § 1301.26 (2006) ("Any individual who has in his/her possession a
controlled substance ... may enter or depart the United States ....").
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where [a] person has undergone treatment."'192 Short-term "tour
ists," frequently retirees on fixed incomes, who take bus rides over
the Canadian or Mexican borders to buy their prescription
medicines, routinely rely upon the CSA exemption and the FDA
guidance. 193
U.S. patients in increasing numbers have looked to the In
ternet to acquire "gray-market" drugs. The first generation of on
line prescribing sites apparently featured licensed doctors who
reviewed questionnaire-based histories before writing prescriptions
that were then forwarded to associated pharmacy operations for
mail-order fulfillment.1 94 In reality, most of these prescribing sites
used contract ghostwriters of suspect licensure to rubber-stamp the
prescriptions. 195 Viewing a fight against online prescribing as part
of the "war on drugs," U.S. states amended their physician licen
sure rules to essentially outlaw this gray market 196 by requiring a
"traditional" or "proper" relationship between the prescribing phy
sician and the patient designed to guarantee in-person contact or a
"good faith prior examination."197 At the same time, federal and
state authorities have become more rigorous in regulating the activ
ities of online U.S. pharmacies.1 98 As a result and not surprisingly,
the suppliers have moved offshore. No longer a "gray" area, the

192.

Terry, Prescriptions sans Frontieres, supra note 62, at 206-07 (quoting Marvin

A. Blumberg, FDA, Information on the Importation of Drugs, Prepared by the Division

of Import Operations and Policy, FDA (Apr. 3, 1998), http://www.fda.gov/ora/importl
pipinfo.htm); see also FDA, OFF. OF REGULATORY AFF., REGULATORY PROCEDURES
MANUAL: CHAPTER 9, SUBCHAPER COVERAGE OF PERSONAL IMPORTATIONS (2006),
available at http://www.fda.gov/ora/compJiance_ref/rpm_new2/ch9pers.html.
193. See, e.g., Alexander Colhoun, Get on the Bus: Extreme Answers to Prescrip
tion Drug Costs, CHRISTIAN SCI. MONITOR, Apr. 18,2000, at 3, available at http://www.
csmonitor.coml2000/0418/p3sl.html; Randi Hunter Epstein, Some Retirees Look
Abroad for Prescription Drugs, N.Y. TIMES, Sept. 24, 2002, at FS, available at 2002
WLNR 4068017 (Westlaw).
194. See, e.g., State ex reI. Stovall v. ConfiMed.com, L.L.c., 38 P.3d 707 (Kan.
2002) (prosecution of questionnaire-prescribing doctor following a state "sting"
operation).
19S. See, e.g., United States v. Nelson, 72 Fed. App'x 837 (10th Cir. 2003), affd,
383 F.3d 1227 (10th Cir. 2004).
196. See Terry, Prescriptions sans Frontieres, supra note 62, at 204.
197. See, e.g., CAL. Bus. & PROF. CODE § 2242(a) (West 2006); ARIZ. REV. STAT.
ANN. § 32-18S4 (West 2006).
198. See, e.g., United States v. Rx Depot, Inc., 438 F.3d lOS2 (10th Cir. 2006); see
also Bob Tedeschi, Pharmacies Endorse Crackdown on Fraud, N.Y. TiMES, Oct. 24,
200S, at C4, available at 200S WLNR 17161884 (Westlaw) (noting the closing of 4,600
illegal Internet pharmacy sites by federal drug investigators).
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issue is now one of practical enforcement. 199 Faced with millions of
foreign-sourced drug shipments into the United States each year,2oo
law enforcement has tried to slow the traffic with the help of credit
card companies,201 shippers,202 and even Internet search engines. 203
The matter might have ended there had it not been for the
quite unprecedented entry of several U.S. states into the gray mar
ket enterprise. Numerous states and municipalities, concerned
about prescription drug costs,2°4 have encouraged reimportation
and petitioned the FDA for a waiver,205 or even set up their own
reimportation plans. 206 Throughout, the FDA has successfully de
fended its policy before the federal courts207 and been resolute in its
opposition to state reimportation initiatives. For example, in a 2006
response to a waiver application from the State of Washington, the
Agency stated:
Granting a waiver that permits the importation of prescription
drugs from Canada, U .K., Ireland, and other foreign countries
will not only result in violations of federal law, but could also put
Washington State citizens at risk. FDA approves a drug based on
scientific data submitted by the drug sponsor to demonstrate that
the drug is safe and effective. We cannot provide adequate assur
199. See generally Prescription Drugs, Preliminary Observations on Efforts to En
force the Prohibitions on Personal Importation: Hearing Before the S. Permanent Sub
comm. on Investigations, Comm. on Governmental Affairs, 109th Congo (2004)
(statement of Richard M. Stana, Dir., Homeland Security & Justice Issues), available at
http://www.senate.gov/-govt-aff/_files/072204stana~a03494.pdf.

200. See, e.g., A New Source for Discount Prescriptions, N.Y. TIMES, Dec. 26,
2002, at A36, available at 2002 WLNR 4442939 (Westlaw).
201. See, e.g., Gilbert M. Gaul & Mary Pat Flaherty, Firms Pressed on Internet
Drugs; Senate Panel Writes to Credit Card Companies, Shippers, WASH. POST, Dec. 10,
2003, at A4, available at LEXIS.
202. See, e.g., Rick Brooks, FedEx and UPS Say They Shun Parcels Containing
Illicit Drugs, WALL ST. J., Jan. 9, 2004, at AS, available at LEXIS.
203. See, e.g., Gilbert M. Gaul & Mary Pat Flaherty, Google to Limit Some Drug
Ads; Web Giants Asked to Help Discourage Illicit Online Pharmacies, WASH. POST,
Dec. 1,2003, at AI, available at 2003 WLNR 5S0S635 (Westlaw).
204. For examples of cost savings, see Cross-border Rx, CBC NEWS ONLINE, Jan.
17, 2006, http://www.cbc.ca/news/background/drugs.
205. See, e.g., STATE OF VT. AGENCY OF ADMIN., CITIZEN PETITION FOR WAIVER
(2003), available at http://www.vermontpersonnel.orgiemployee/pdflFDAPetition120
703.pdf. The FDA subsequently rejected the petition. Letter from William K. Hub
bard, Assoc. Comm'r for Pol'y & Planning, FDA, to Michael K. Smith, Sec'y of Admin.,
State of Vt. (Aug. 4, 2004), available at http://www.vermontpersonnel.orglhtrnlpdflFDA
Denial.pdf.
206. See Terry, Prescriptions sans Frontieres, supra note 62, at 207-17.
207. See, e.g., Andrews v. U.S. Dep't of Health & Human Servs., No. 04-0307,
2005 U.S. Dist. LEXIS 5710 (D.D.C. Mar. 31,2005); Vermont v. Leavitt, 405 F. Supp.
2d 466 (D. Vt. 2005).
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ance to your constituents that the drug products delivered to
them from foreign countries are the same products approved by

FDA.208
Undeterred and increasingly irritated with the federal govern
ment,209 several states have persisted and jointly sponsor I-Save
RX, a website developed by the governor of Illinois but now also
serving residents of Wisconsin, Kansas, Missouri, and Vermont. 210
I-Save RX uses a Canadian PBM as an intermediary,211 and the
PBM sources the drugs from pharmacies and wholesalers in Ca
nada, Ireland, the United Kingdom, New Zealand, and Australia.
The I-Save RX program only applies to prescription refills and ex
cludes most controlled substances or drugs that require special han
dling. Under the program, U.S. prescriptions and medical histories
are forwarded to physicians in the supplying countries, apparently
rewritten to comply with local laws, and dispensed by local, licensed
pharmacists who then ship the medicine to the United States. 212
Pharmaceutical manufacturers have attempted to cut off for
eign pharmacies by more rigorously controlling and policing their
wholesale distribution. 213 Not surprisingly, the FDA has targeted
shipments into the United States by I-Save RX suppliers214 and, af
ter lobbying by the United States, Canada's health minister has an
nounced plans to increase regulation of the cross-border trade and
to cut off bulk supplies to the United States. 2IS Critics have even
208. Letter from Randall W. Lutter, Assoc. Comm'r for Pol'y & Planning, FDA,
to Steven M. Saxe, Dir., Wash. State Bd. of Pharmacy (Mar. 17, 2006), available at
http://www.fda.gov/oc/opacom/hottopics/importdrugs/saxe031706.html.
209. See, e.g., Vt. Dep't of Human Res., Tackling the Prescription Drug Crisis,
http://www.vermontpersonnel.orglhtm/prescription.php (last visited Mar. 18, 2007).
210. I-SaveRx, Welcome to I-SaveRx, http://www.i-saverx.net (last visited Mar.
18,2007).
211. CanaRx, Servs., Inc., CanaRx, http://www.canarx.com (last visited Mar. 18,
2007).
212. I-SaveRx, Frequently Asked Questions: Order Questions, http://www.i
saverx.neUenrollment.htm (last visited Mar. 18, 2007).
213. See, e.g., Mark Heinzl & Tamsin Carlisle, Canadian Pharmacies vs. Big Drug
Makers-Online Retailers Vow to Fight Edict Seeking to Clamp Down on Cheap Ex
ports to the U.S., WALL ST. J., Aug. 12,2003, at D4, available at LEXIS; Bernard Simon,
Pfizer Moves To Try To Stop Drugs from Canada, N.Y. TIMES, Jan. 14,2004, at WI,
available at 2004 WLNR 5507399 (Westlaw); Fearing End to Canada Drugs, States Now
Look to Europe, USA TODAY, Jan. 14, 2005, available at http://www.usatoday.com/
newslhealthl2005-01-14-drugs-europe_x.h tm.
214. FDA: Seizes Shipments Imported Through I-Save Rx Program, AM. HEALTH
LINE, Mar. 10, 2005, available at LEXIS.
215. Judith Graham, Canada to Ban Bulk Drug Exports, Allow Internet Sales,
CHI. TRIB., June 30, 2005, at C7, available at 2005 WLNR 23487959 (Westlaw); cf Lisa
Girion, Senate Votes to Ease Drug Imports, L.A. TIMES, July 12, 2006, at C1, available at
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argued that the I-Save RX program creates confusion among con
sumers facing enrollment in the new Medicare Part D216 low-cost
drug plans. 217 Notwithstanding, political pressure and consumer
complaints have finally led the FDA away from seizing small pre
scription shipments and to instead concentrate on larger shipments
of illegal drugs. 218 However, given adverse changes in the U.S.-Ca
nada exchange rate,219 and the relatively small number of orders
processed by I-Save RX (there are 27 million eligible residents, yet
fewer than 20,000 orders were placed in its first two years of opera
tion),220 it may be that the program now primarily functions as a
political symbol.
D.

Clinical Trials

In 2004, pharmaceutical companies spent nearly $39 billion on
research and development. Twenty-one percent of this was spent
outside the U.S. The outsourcing of clinical trials is a relatively new
drug (and device) research and development (R&D) phenomenon
led by the increasing importance of Contract Research Organiza
tions (CROS).221 The major pharmaceutical companies predict that
this outsourcing trend will continue in the near term, with 50-70
percent of clinical trials soon to be performed outside the United
States. 222
2006 WLNR 11980042 (Westlaw) (reporting 2006 House and Senate votes prohibiting
customs seizures of prescription drugs imported or carried over the border by
individuals).
216. The Medicare Part D program was introduced by the Medicare Prescription
Drug, Improvement, and Modernization Act of 2003, Pub. L. No. 108-173, 117 Stat.
2066,2071.
217. Mary Massingale, State Promotional Effort May Confuse Those Dazed by
Medicare Part D, COPLEY NEWS SERV., Dec. 16,2005, available at Westlaw.
218. U.S. to Stop Seizing Canadian Drug Imports; New Policy Allows Seniors to
Order Cheaper Prescriptions Through the Mail, MSNBC.coM, Oct. 4, 2006, http://www.
msnbc.msn.comlid/1S127747.
219. Theresa Agovino, Savings/rom Canada Drug Purchasing Falls, ASSOCIATED
PRESS, Jan. S, 200S (on file with the author).
220. Richard A. Rettig, The Industrialization a/Clinical Research, HEALTH AFF.,
Mar.-Apr. 2000, at 129, 129-46, available at http://content.healthaffairs.orglcgi/reprint/
19/2/129.pdf; Massingale, supra note 217; see also Warren Wolfe, State's Seniors Buy
Fewer Canadian Drugs, STAR TRIB. (Minneapolis-St. Paul), July 12,2006, at B2, avail
able at 2006 WLNR 12097293 (Westlaw) (reporting that sales through the Minnesota
RxConnect reimportation program have dropped to an all-time low).
221. Rettig, supra note 220, at 129-46.
222. Julie Schmit, Costs, Regulations Move More Drug Tests Outside USA, USA
TODAY, May 16, 200S, available at http://www.usatoday.com/money/industrieslhealth/
drugs/200S-0S-16-drug-trials-usacx.h tm.
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The growth of offshore trials is partly explicable by the oppor
tunities that manufacturers now have for concurrent, rather than
sequential (to use the U.S. term), New Drug Applications223 across
several jurisdictions. 224 It is also a function of dramatically lower
offshore costs and, according to critics, a way for drug companies to
distance themselves from U.S. regulatory scrutiny.225
As with medical tourism, and stimulated by increasingly West
friendly intellectual property laws,226 domestic and U.S.-owned
CROs are blossoming in India. 227 Trials are performed in India at
40-60 percent of their cost in Western countries. 228 A large cohort
of English-speaking researchers, and a massive patient population
with genetically distinct subsets, makes India a particularly attrac
tive location. 229 Offshore medical trials involving human subjects
are also increasing in Thailand, Africa, China, and Latin America.
In The Body Hunters, a series of articles published in The
Washington Post in 2000, investigators detailed offshore human ex
perimentation that was marred by inadequate, untranslated, or
forged consents, deficient supervision by local ethics committees or
FDA investigators, and medical care of participants that met only
local, not U.S., standards. 230 One such study investigated was Pfizer
223. See FDA, Ctr. for Drug Evaluation & Research, New Drug Application
(NDA) Process, http://www.fda.gov/cder/regulatory/applicationsINDA.htm (last visited
Mar. 18, 2007).
224. For example, lobbying from international pharmaceutical companies led In
dia to remove the "phase lag" theretofore required by its Drugs and Cosmetics rules.
See Samiran Nundy & Chandra M. Gulhati, A New Colonialism?-Conducting Clinical
Trials in India, 352 NEW ENG. J. MED. 1633, 1633 (2005).
225. Schmit, supra note 222.
226. Gunjan Sinhu, Outsourcing Drug Work: Pharmaceuticals Ship R&D and
Clinical Trials to India, SCI. AM., Aug. 16, 2004, at 24.
227. K. S. Jayaraman, Outsourcing Clinical Trials to India Rash and Risky, Critics
Warn, 10 NATURE MED. 440 (2004), available at http://www.pridco.com/english/media_
center/pdCproxy.php?pdUd=352.
228. Id.; Sinhu, supra note 226.
229. Jayaraman, supra note 227; see also Nundy & Gulhati, supra note 224, at
1634.
230. Joe Stevens, Where Profits and Lives Hang in Balance; Finding an Abun
dance of Subjects and Lack of Oversight Abroad, Big Drug Companies Test Offshore to
Speed Products to Market, WASH. POST, Dec. 17,2000, at AI, available at LEXIS; Mary
Pat Flaherty et aI., Testing Tidal Wave Hits Overseas: On Distant Shores, Drug Firms
Avoid Delays-and Scrutiny, WASH. POST, Dec. 18,2000, at AI, available at LEXIS;
Estonia Parnu, The Dilemma: Submit or Suffer; 'Uninformed Consent' Is Rising Ethic of
the Drug Test Boom, WASH. POST, Dec 19, 2000, at AI, available at LEXIS; John Pom
fret & Deborah Nelson, An Isolated Region's Genetic Mother Lode; Harvard-Led Study
Mined DNA Riches: Some Donors Say Promises Were Broken, WASH. POST, Dec. 20,
2000, at AI, available at LEXIS; Karen DeYoung & Deborah Nelson, Latin America Is
Ripe for Trials, and Fraud: Frantic Pace Could Overwhelm Controls, WASH. POST, Dec.
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Inc.'s Nigerian trials of "Trovan,"231 an antibiotic, on children, re
sulting in multiple deaths and injuries. A subsequent Nigerian gov
ernment investigation reportedly concluded that the research was
illegal, and, contrary to allegedly altered documentation, the re
search had not been approved in advance by a Nigerian ethics com
mittee. 232 Lawsuits brought against Pfizer in U.S. federal courts for
alleged violations of international law, specifically, the Nuremberg
Code and the Declaration of Helsinki, were dismissed for lack of
subject matter jurisdiction under, inter alia, the Alien Tort Stat
ute 233 and because of forum non conveniens,234 notwithstanding ev
idence of severe deficiencies in parallel legal proceedings in
Nigeria. 235 The fictionalized account in The Constant Gardener
may be the victims' only memorial.236
The Common Rule 237 applies to all federally funded research
involving human subjects, wherever it takes place. 238 As a result,
Institutional Review Boards (IRBs)239 and other domestic safe
21,2000, at AI, available at LEXIS; Mary Pat Flaherty & Doug Struck, Life by Luck of
the Draw; In Third World Drug Tests, Some Subjects Go Untreated, WASH. POST, Dec.
22, 2000, at AI, available at LEXIS.
231. Trovan is the Pfizer brand name for trovafloxacin mesylate.
232. Joe Stevens, Panel Faults Pfizer in '96 Clinical Trial in Nigeria; Unapproved
Drug Tested on Children, WASH. POST, May 7,2006, at AI, available at LEXIS.
233. 28 U.S.c. § 1350 (2000).
234. Adamu v. Pfizer, Inc., 399 F. Supp. 2d 495, 504-06 (S.D.N.Y. 2005); Abdul
lahi v. Pfizer, Inc., Nos. 12677, 12678 (WHP), 2005 U.S. Dist. LEXIS 16126, at *54
(S.D.N.Y. Aug. 9, 2005).
235. Abdullahi, 2005 U.S. Dist. LEXIS 16126, at *47-52.
236. JOHN LE CARRE, THE CONSTANT GARDENER (2000); see also Marcia An
gell, The Body Hunters, N.Y. REV. BOOKS, Oct. 6, 2005, at 23, 23-25 (reviewing THE
CONSTANT GARDENER (Universal Pictures 2005) and discussing the overlap of fact and
fiction).
237. The Federal Policy for the Protection of Human Subjects, often referred to
as the "Common Rule," has been adopted by seventeen federal agencies. It provides
for human subject protection by conditioning such research on institutional assurances,
institutional review board (IRB) review, and the informed consent of subjects. See, e.g.,
U.S. Dep't of Health & Human Servs., Off. for Human Research Prot., Policy Gui
dance, Common Rule, http://www.hhs.gov/ohrp/policy/#common (last visited Mar. 18,
2007).
238. 45 C.F.R. § 46.101 (2005).
239. The FDA describes the role of an IRB as follows:
Under FDA regulations, an IRB is an appropriately constituted group
that has been formally designated to review and monitor biomedical research
involving human subjects. In accordance with FDA regulations, an IRB has
the authority to approve, require modifications in (to secure approval), or dis
approve research. This group review serves an important role in the protec
tion of the rights and welfare of human research subjects.
The purpose of IRB review is to assure, both in advance and by periodic
review, that appropriate steps are taken to protect the rights and welfare of
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guards apply.240 As Alice Page has noted, however, these safe
guards are almost exclusively procedural and "provide no guidance
to IRBs or researchers about how ethics should be used as a mecha
nism for protecting human research subjects."241
Non-government-funded research (such as that performed by
pharmaceutical companies or CROs) is not subject to the Common
Rule. However, research leading to a U.S. drug New Drug Appli
cation or device Premarket Approval Application must be per
formed in compliance with generally applicable FDA rules. U.S.
clinical studies must be performed under a U.S. Investigational
New Drug Application (IND) or an Investigational Device Exemp
tion (IDE). Foreign-based research does not require an IND or
IDE, but the research sponsors can choose to apply for one; there
after, all U.S. safeguards should apply.242
If the research is not performed under an IND or IDE, and
involves foreign subjects, FDA rules require that the research is
conducted in accordance with the ethical principles stated in the
Declaration of Helsinki or local legal protections, whichever is
greater. 243 Federal European standards take a similar approach, in
corporating Helsinki and other international norms.244
In theory, therefore, offshore clinical trials are conditioned on
similar qualitative and subject protections as U.S. trials. The differ
ence, however, is in the level of inspection and scrutiny. For exam
ple, serious questions have been raised about the adequacy of the
medical infrastructure in India to support quality trials, the training
humans participating as subjects in the research. To accomplish this purpose,
IRBs use a group process to review research protocols and related materials
(e.g., informed consent documents and investigator brochures) to ensure pro
tection of the rights and welfare of human subjects of research.
FDA, Guidance for Institutional Review Boards and Clinical Investigators, Frequently
Asked Questions (1998), http://www.fda.gov/oc/ohrtlirbs/faqs.html.
240. See, e.g., 4S C.F.R. § 46.103. If non-U.S. sites are involved, a Federalwide
Assurance of compliance with the U.S. federal regulations is required. See U.S. Dep't
of Health & Human Servs., Off. for Human Research Prot., Step-by-Step Instructions
for Filing a Federalwide Assurance for International (Non-U.S.) Institutions (June 6,
200S), http://www.hhs.gov/ohrp/humansubjects/assurance/ifilasuri.htm.
241. Alice K. Page, Ethical Issues in International Biomedical Research: An Over
view, 37 I. HEALTH L. 629,636 (2004).
242. 21 C.F.R. §§ 312.120, 814.1S(a) (2006).
243. 21 C.F.R. §§ 312.120(c)(1), 814.1S(b). See generally FDA, GUIDANCE FOR
INDUSTRY: ACCEPTANCE OF FOREIGN CLINICAL STUDIES (2001), available at http://
www.fda.gov/cder/guidance/fstud.pdf.
244. See, e.g., Commission Directive 200S/28, 200S 0.1. (L 091) 13, available at
http://europa.eu.intieur-lex/lexiLexUriServ/LexUriServ.do?uri=CELEX:3200SL0028:
EN:HTML.
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of Indian researchers, the quantity and quality of Indian IRBs, and
the local ethical standards (including informed-consent deficien
cies) applied in dealing with subjects. 245 In a 2001 report, which
was triggered by The Body Hunters and confirmed the dramatic in
crease in the number of offshore clinical trials, the U.S. Department
of Health and Human Services' Office of Inspector General (OIG)
found key differences in the scrutiny of offshore trials. 246 Specifi
cally, the OIG noted deficiencies in the FDA's tracking of non-IND
trials, the absence of FDA inspection of foreign IRBs, the lack of
any "attestation" requirement for non-IND investigators and a fail
ure to enforce attestation for foreign-based INDs, and generalized
staffing, political, and logistical deficiencies that challenged rigor
ous FDA inspection of foreign research sites. 247
III.

GLOBALIZATION, HEALTH MARKETS, AND
REGULATORY DILEMMAS

What can one conclude from this brief survey of medical tour
ism and outsourcing? Tourists who seek to leverage more favorable
socio-medical policies (such as assisted suicide), or outsourcers
looking to avoid quality or public-health-related regulation (such as
acquiring drugs without prescriptions), may, for now, be dismissed
as outliers. Most of the other scenarios described above rotate
around international or regional cost vectors. Western tourists
travel internationally for cheaper procedures, while Europeans
travel regionally to avoid price-related rationing in their states of
residence. U.S. hospitals outsource patient and hospital services
(such as HIT and imaging) in search of reduced professional labor
costs or surplus professionals. Western pharmaceutical companies
testing their drugs seek both lower cost subjects (a function of re
duced regulatory scrutiny) and less expensive researchers.
These cost-driven transfers are hardly surprising. The United
States spends considerably more on health care than any other
country, yet is below the Organisation for Economic Co-Operation
and Development (OECD) median on service utilization.248 Ger
245. Nundy & Gulhati, supra note 224, at 1634.
246. U.S. DEP'T OF HEALTH & HUMAN SERVS., OFF. OF INSPECTOR GEN., THE
GLOBALIZATION OF CLINICAL TRIALS 15-16 (2001), available at http://oig.hhs.gov/oeil
reports/oei-01-00-00190. pdf.
247. [d. at 6-14; see also Jennifer Kahn, A Nation of Guinea Pigs, WIRED MAG.,
Mar. 2006, available at http://www.wired.com/wired/archive/14.03/indiadrug.html.
248. Cf MICHAEL F. CANNON & MICHAEL D. TANNER, HEALTHY COMPETITION:
WHAT'S HOLDING BACK HEALTH CARE AND How TO FREE IT 18-25 (2005) (conceding
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aId Anderson and colleagues concluded that the primary difference
between the United States and the health care systems of other
countries is much higher pricing in the former. 249 They observed
that the major reason for disparate pricing across national borders
is the variable of "the degree to which [different countries] try to
whittle away at the rent earned on the supply side through the crea
tion of market power on the buy (monopsony) side of the mar
ket."250 Thus, medical tourists and outsourcers (a perfect example
is a U.S. state reimporting drugs from Canada) are in most cases
seeking to leverage the vector between domestic and offshore levels
of government intervention on the buy side.
Anderson and colleagues also addressed the question of why
the global health care market fails to diminish national differences
in buy-side policies (and hence prices ).251 Their explanation was
that health care features poorly functioning domestic markets and
trade-limiting barriers between domestic markets. 252 Most of the
domestic market failures lie outside the scope of this Artic1e. 253
However, the growing traction of "consumer-directed" health care,
the latest in a long line of attempts to cure America's runaway
health care costs,254 is worth noting. Consumer Directed Health
care Plans (CDHPs) have features such as high deductibles and
work in tandem with personal Health Savings Accounts (HSAs)
all apparently designed to reduce misaligned incentives inherent in
U.S. health care (because of, it is argued, over-reliance on third-

that there is waste in the system due to, for example, government intervention, but
arguing that high levels of spending are partly attributable to high income, elderly
populations, beneficial technological advances, and that the United States outperforms
other countries with regard to cancer patients and low-birth-weight infants).
249. Gerard F. Anderson et aI., It's the Prices, Stupid: Why the United States is so
Different from Other Countries, HEALTIl AFF., May-June 2003, at 89, 89-90, available at
http://www.medscape.com!viewarticle/452954_1.
250. Id. at 102; see also Reinhardt et aI., supra note 139, at 10-25. In the present
U.S. market, it takes aggressive pressure on the buy-side to have even minimal effects
on pricing. See Scott Hensley, Big Buyers Push for Steep Price Cuts From Drug Mak
ers, WALL ST. J., June 22, 2006, at Bl, available at LEXIS.
251. Anderson et aI., supra note 249.
252. Id. at 101-02 ("[NJeither the goods and services nor all of the inputs that
produce them are perfectly mobile across countries.").
253. But see generally CANNON & TANNER, supra note 248.
254. For a chronological treatment of attempts to cure health care costs including
CDHPS, see Uwe E. Reinhardt, Churchill's Dictum and the Next New Thing in Ameri
can Health Care, 38 Bus. ECON., July 2003, at 3.
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party payment and decision-making)255 and to empower consumers
to make "market decisions" about how "their" health care dollars
will be spent. 256 However, as related by Edward Larson and Marc
Dettmann, preliminary indications are that HSAs "will have little
impact on rising health care costs or shrinking health care ac
cess."257 Nevertheless, if consumer-directed health care does prove
effective, patients with unfettered access to low-cost foreign health
care or heavily outsourced domestic health care may well spend
"their" care dollars abroad. 258
A.

Barriers to Health Care Trading

At first sight, the number of tradable medical procedures ap
pears to be relatively low. Self-evidently, the patient must be able
to travel. But the pool of ambulatory patients has barely been
tapped. In fact, the combination of tourism and outsourcing sug
gests that the number of tradable medical events should increase.
Even with an as yet unmet practical ceiling on tourism, the continu
ing disaggregation of domestic care, coupled with outsourcing of
many of its components (for example, offshoring of ICU monitor
ing or radiology triaging), suggests that physical or practical barriers
are not determinative. The question arises, therefore, whether
there are other barriers to medical trading that either limit current
activity or are likely to cap it in the future.
1.

Regulation and Trade Barriers

Policymakers, legislators, and professionals have never shown
much enthusiasm for a flat health care world, even within their own
borders. For example, in Europe, the Treaty of Rome and its prog
eny have left health care policy and financing as a matter primarily
for the member states. 259 Within the United States, the question of
who would regulate physicians was answered as early as 1889,
"when the Supreme Court denied a due-process challenge to a West
Virginia medical practice act which required state licensure of phy
255. See generally John V. Jacobi, After Managed Care: Gray Boxes, Tiers and
Consumerism, 47 ST. LOUIS U. L.J. 397 (2003); Greg Scandlen, Consumer-Driven
Health Care: Just a Tweak or a Revolution?, 24 HEALTH AFF. 1554 (2005).
256. See CANNON & TANNER, supra note 248, at 66-73.
257. Edward J. Larson & Marc Dettmann, The Impact of HSAs on Health Care
Reform: Preliminary Results After One Year, 40 WAKE FOREST L. REV. 1087, 1123
(2005).
258. See Scandlen, supra note 255, at 1554, 1557.
259. See, e.g., Germany v. Parliament, Case C-376/98, 2000 E.C.R. 1-08419 (invali
dating pan-European tobacco advertising law).
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sicians."26o Only relatively recently, and not universally,261 have
national standards begun to prevail over local ones in malpractice
cases. 262 Even HIPAA's "national" standard of health care infor
mation confidentiality is undercut by its partial preemption rule
that favors "more stringent" state laws. 263
Somewhat ironically, health care's ignorance that there is a flat
world has also been responsible for a relative dearth of legal rules
explicitly designed to impede medical trading. Obviously, immigra
tion rules limit the freedom of movement of highly trained medical
specialists, creating a supply-side surplus in some less-industrialized
countries. As a result, notwithstanding initiatives such as the J-1
Visa Waiver program,264 developed countries have been unable to
satisfy their demand for foreign-trained doctors, and more recently,
for nurses. 265 However, providers simply end-run this barrier with
260. Terry, Prescriptions sans Frontieres, supra note 62, at 190 (citing Dent v.
West Virginia, 129 U.S. 114, 122 (1889)).
261. See, e.g., Estate of Hagedorn v. Peterson, 690 N.W.2d 84, 90 (Iowa 2004)
(approving jury instruction using a variant of the locality rule).
262. See, e.g., Morrison v. MacNamara, 407 A.2d 555, 565 (D.C. Cir. 1979); Hall
v. Hilbun, 466 So.2d 856, 872 (Miss. 1985); Sheeley v. Mem'l Hosp., 710 A.2d 161, 167
(R.I. 1998).
263. 45 C.F.R. § 160.202 (2005); see, e.g., U.S. ex reI. Pogue v. Diabetes Treatment
Ctrs. of Am., No. 99-3298,2004 U.S. Dist. LEXIS 21830, at *10 (D.D.C. May 17,2004);
Nat'l Abortion Fed'n v. Ashcroft, No. 03 Civ. 8695 (RCC), 2004 U.S. Dist. LEXIS 4530,
at *17 (S.D.N.Y. Mar. 18,2004).
264. The Rural Initiative-J-1 Visa Waiver program, permits a U.S. Department
of Health and Human Services/Immigration and Naturalization Service "waiver[] of
[the] return-home requirement for foreign physicians who [have] trained in the United
States" but who are prepared to stay and work in health professional shortage or medi
cally underserved areas. Press Release, U.S. Dep't of Health & Human Servs., The
Rural Initiative-J-1 Visa Waiver (Dec. 17,2002), available at http://www.hhs.gov/rural
initiative/waiver.html. For information on the effectiveness of the program, see Foreign
Physicians: Preliminary Findings on the Use of J-l Visa Waivers to Practice in Under
served Areas: Hearing Before the Subcomm. on Immigration, Border Security and
Claims of the H. Comm. on the Judiciary, 109th Congo (2006) (statement of Leslie G.
Aronovitz, Dir., Health Care Issues, U.S. Gen. Accounting Off.), available at http://
www.gao.gov/new.items/d06773t.pdf.
265. The supply of foreign trained nurses into the United States was robust (with
12,000 to 14,000 annual green cards) until the backlog of 2005. Celia W. Dugger, U.S.
Plan to Lure Nurses May Hurt Poor Nations, N.Y. TIMES, May 24, 2006, at AI, available
at 2006 WLNR 8880889 (Westlaw). The Comprehensive Immigration Reform Act of
2006 attempted to remedy this by removing the cap on the immigration of nurses for
seven years. Comprehensive Immigration Reform Act of 2006, S. 2611, 109th Congo
(2006); see Press Release, Sam Brownback, U.S. Sen., Brownback Comments on Immi
gration Bill Passage (Mar. 27,2006), available at http://brownback.senate.gov/pressapp/
record.cfm?id=253170. However, the overall immigration package was unable to
achieve House approval. See Adam Nagourney et aI., Bush's Immigration Plan Stalled
As House G.O.P. Grew Anxious, N.Y. TIMES, June 25, 2006, at AI, available at 2006
WLNR 10985951 (Westlaw).
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outsourcing; immigration may be restricted, but there are minimal
barriers to sending dis aggregated services (e.g., imaging) offshore
to be processed by those same surplus professionals.
Not surprisingly, some legal rules that impede interstate trade
(e.g., licensure) will have the potential to create barriers to interna
tional trade. Take, for example, teleradiology. As already noted,
the preliminary report made by the non-U.S. radiologist should be
followed, upon transmittal back to the United States, by a final re
port from a domestic radiologist who has examined the image. 266
Domestic providers, possibly aware that local ethical and legal rules
can be exploited for protectionist purposes, argue that the U.S.
component frequently consists of no more than "ghosting."267 In
May 2006, the American College of Radiology issued a practice
statement on this issue, stating that:
It is unethical and likely fraudulent for a physician who has not

personally interpreted the images obtained in a radiologic exami
nation to sign a report or to take attribution of an interpretation
of that examination rendered by another physician in a manner
that causes the reader of a report to believe that the signing radi
ologist was the interpreter. This practice, known as ghost report
ing, should be strictly prohibited. 268

The College also called for the outsourced interpreters to possess
dual licensure (both in the place where the image was obtained and
where interpreted), to be credentialed by the facility where the im
age was obtained, to have valid malpractice coverage in the state
where the image was obtained, and to submit to U.S. jurisdiction.269
If tourism continues to increase apace, hospitals may join doc
tors in looking nervously at the foreign competition. The contro
versy surrounding domestic, physician-owned specialty hospitals
that leverage the "whole hospital" exception to self-referral
prohibitions270 may be predictive. These facilities allegedly cherry
pick "easier" (and hence more profitable) patient referrals and
266. See supra text accompanying notes 177-178.
267. Stein, supra note 167 (describing "ghosting" as the practice of "radiology
operations ... staffed with one or two U.S.-certified radiologists who approve reports
prepared by less-qualified technicians"); see infra note 268 and accompanying text
(describing "ghost reporting").
268. Am. Coll. of Radiology, Revised Statement on the Interpretation of Radiol
ogy Images Outside the United States (May 2006), available at http://www.acr.orgls_acr/
doc.asp?CID=541&DID=24137.
269. Id.
270. Stark Regulations, 42 C.F.R. §§ 411, 424 (2005).
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higher-margin Diagnosis-Related Groups.271 After extensive lob
bying by traditional hospitals, the MMA272 introduced a since-ex
tended moratorium on such hospitals. 273 High-profit surgical
procedures and the government research grants that rotate around
them cross-subsidize routine and indigent care. At some point hos
pitals may view medical-tourism centers as jeopardizing this busi
ness model by skimming off their most profitable patients and seek
protectionist regulation.
Pharmaceutical companies possess an array of legal mecha
nisms, national intellectual property laws being the most obvious, to
impede pharmaceutical arbitrage. But, to find a public law barrier
to the reimportation of drugs from Canada, the FDA had to dig
deep into the minutiae of the FDCA and supplement it with a me
dia-friendly "quality" argument. 274 In fact, the FDA's interpreta
tion of the FDCA likely is correct. 275 The problem is that the
agency's motives are suspect, determined less by genuine quality
concerns and more by a desire to shore up a governmental policy
opposed to any intervention in the pharmaceutical market. As Ke
vin Outterson has observed, either pharmaceutical rents in the
United States are supra-optimal, or the pharmaceutical industry has
been less than transparent in their counter-arguments. 276 The ad
ministration readily accepted the MMA prohibition on buy-side in
271. Medicare Prescription Drug, Improvement, and Modernization Act of 2003,
Pub. L. No. 108-173, § 507,117 Stat. 2066, 2295 (amending 42 U.S.c. § 1395nn(d)(3»
(Diagnosis-Related Groups); see, e.g., Am. Hosp. Directory, Medicare Prospective Pay
ment System, http://www.ahd.comipps.html(last visited Mar. 18, 2007). See generally
Phillip L. Ronning & Michael Nugent, Freestanding Heart Hospitals: Is the End Near?,
HEALTHCARE FIN. MGMT., Sept. 2004, at 94.
272. Medicare Prescription Drug, Improvement, and Modernization Act of 2003,
§ 507.
273. See generally Letter from A. Bruce Steinwald, Dir., Health Care, U.S. Gov't
Accountability Off., to Charles Grassley, Chairman, and Max Baucus, Ranking Minor
ity Member, S. Comm. on Finance (May 19, 2004), available at http://www.gao.gov/new.
items/d05647r.pdf (discussing specialty hospitals and potential new facilities).
274. See supra note 208 and accompanying text; see also U.S. GEN. ACCT. OFF.,
INTERNET PHARMACIES: SOME POSE SAFETY RISKS FOR CONSUMERS, REPORT TO THE
CHAIRMAN, PERMANENT SUBCOMMITTEE ON INVESTIGATIONS, COMMITTEE ON Gov
ERNMENTAL AFFAIRS, U.S. SENATE 13 (2004), available at http://www.gao.gov/new.

items/d04820.pdf.
275. See Andrews v. U.S. Dep't of Health & Human Servs., No. 04-0307 (JR),
2005 U.S. Dist. LEXIS 5710 (D.D.C. Mar. 31, 2005); Vermont v. Leavitt, 405 F. Supp.
2d 466 (D. Vt. 2005).
276. Kevin Outterson, Pharmaceutical Arbitrage: Balancing Access and Innova
tion in International Prescription Drug Markets,S YALE J. HEALTH POL'y L. & ETHICS
193, 197 (2005).
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tervention 277 and has been equally steadfast in hindering the
supply-side pressures that would come with reimportation.
Some domestic regulations applicable to health care are explic
itly extraterritorial. For example, the EU data directive extends its
reach to offshore medical data processing,278 a position that created
tensions with the United States until the adoption of a safe-harbor
model.279 In contrast, HIPAA appears unaware of any transna
tional issues. Notwithstanding, outsourcers and their offshore part
ners will have to be aware of the occasional state regulation, such as
California's identity-theft statute, which applies to anyone who
"conducts business in California" and imposes a duty to disclose
any security breach to affected California residents. 28o
Of course, protectionist legislation is often only one good inter
national "episode" headline away from passage. In 2004, after me
dia coverage of the rogue medical transcriber in Pakistan,
Congressman Markey proposed the Personal Data Offshoring Pro
tection Act, which provided for notification to the patient prior to
offshore outsourcing and would have required the patient to opt-in
before outsourcing to countries with low levels of protection. 281
Similar legislation282 passed in California but was vetoed by Gover
nor Schwarzenegger. 283
277. 42 U.S.c. § 1395w-l11(i) (Supp. 2003) ("In order to promote competition ...
and in carrying out this part ... the Secretary-(I) may not interfere with the negotia
tions between drug manufacturers and pharmacies and PDP sponsors; and (2) may not
require a particular formulary or institute a price structure for the reimbursement of
covered part D drugs.").
278. Council Directive 95/46 of 24 Oct. 1995 on the Protection of Individuals with
Regard to the Processing of Personal Data and on the Free Movement of Such Data,
arts. 25-26, 1995 OJ. (L 281) 31 (EC).
279. U.S. Dep't of Commerce, Welcome to the Safe Harbor, http://www.export.
gov/safeharbor/index.html (last visited Mar. 18, 2007). For a survey of different health
information protective systems, see generally Nicolas P. Terry, Privacy and the Health
Information Domain: Properties, Models and Unintended Results, 10 EUR. J. HEALTH L.
223,228 (2003). See also EU, U.S. Reach Deal on Sharing Passenger Data from Trans
Atlantic Flights, USA TODAY, Oct. 6, 2006, available at http://www.usatoday.comltravel/
news/2006-10-06-eu-us-flier-data_x.htm; Press Release, The Working Party, Press Re
lease on the SWIFT Case, Following the Adoption of the Article 29 Working Party
Opinion on the Processing of Personal Data by the Society for Worldwide Interbank
Financial Telecommunication (SWIFT) (Nov. 23, 2006), available at http://ec.europa.eu/
justice_home/fsj/privacy/news/docsIPR_SwifCAffair_23_11_06_en.pdf.
280. CAL. CIv. CODE § 1798.82(a) (West 2006).
281. See, e.g., Personal Data Offshoring Protection Act of 2004, H.R. 4366, 108th
Congo § 3 (2004).
282. S. 1492,2003-2004 Sess. § 56.32(b) (Cal. 2004).
283. John M. Hubbell & Mark Martin, Governor Vetoes Bills on Offshoring Jobs:
Legislation Bans Foie Gras Starting in 2012, S.F. CHRON., Sept. 30, 2004, at Bl, available
at 2004 WLNR 7621668 (Westlaw).
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Limitations on Coverage and the Politics of the
Underinsured

In a recent Health Affairs article, Aaditya Mattoo and
Randeep Rathindran argue that the primary barrier to increased
medical tourism from the United States is a lack of coverage under
existing health insurance policies. 284 They argue that the United
States health care bill could be reduced by up to $2 billion per an
num if policies provided a tourism option that included travel ex
penses. 285 Other than explicit protectionist policies by or impacts
on government-funded health care (e.g., Medicare and Medicaid),
the authors suggest that tourism coverage is not generally included
because of indeterminacies associated with quality and liability ex
posure, monitoring costs associated with distant providers, and pos
sible oligopolistic behavior by insurers.286
As already noted, some Western insurers are making modest
entries into overseas fulfillment. 287 With experience, some of these
posited barriers may resolve. Near term, Western insurers and
policymakers likely will use the threat of overseas fulfillment as a
bargaining tool with domestic health care providers. In June 2006,
the Senate Special Committee on Aging held hearings on medical
tourism. 288 The Committee heard testimony from a family member
of a medical tourist, an employer, an insurer, a tourism intermedi
ary, and a U.S. plastic surgeon. 289 Many of the issues discussed
herein surfaced in some manner. However, the overall tone of the
proceedings had less to do with tourism per se and more to do with
the costs of domestic care. For legislators, medical tourism as it
currently exists may be an epiphenomenon; like the reimportation
of drugs from Canada, it is less of an issue requiring regulatory ad
justment and more of a wedge to insert into the debate over health
care costs and the plight of the underinsured. That such a wedge
can prove effective is illustrated by the contract between the Amish
and Mennonite communities and the Lancaster Regional Center in
Pennsylvania. Willing to pledge against malpractice claims, pay in
284. Aaditya Mattoo & Randeep Rathindran, How Health Insurance Inhibits
Trade in Health Care, 25 HEALTH AFF. 358, 360 (2006).
285. Id. at 362.
286. Id. at 364-66.
287. See supra text accompanying note 37.
288. The Globalization of Health Care: Can Medical Tourism Reduce Health Care
Costs? Hearing Before the S. Special Comm. on Aging, 109th Congo (2006), available at
http://aging.senate.govlhearing...detail.cfm ?id=270728&.
289. Id.
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cash, and contract for a limited number of health care services, the
communities negotiated discounted flat-rate payments for the ser
vices they required-their negotiations were informed by their ex
periences with regular travel to Mexico for discounted health care
services. 29o
3.

Quality and Compensation Costs

Considerable care is needed in assessing whether quality varia
tions between health care systems are creating barriers to tradable
procedures or offshore outsourcing. First, "quality" is a far more
complex value than the simple absence of error. Second, inherent
in framing the quality-barrier question is the danger of stereotyping
the medical systems in less developed countries. Third, when prov
iders in industrialized countries raise quality issues, their motives
must be examined because of the danger that they may be driven by
protectionism rather than concern for patient health.
As to "quality," Uwe Reinhardt and colleagues291 note that na
tional systems that control costs with rationing frequently do so by
implicit or explicit reference to cost-effective outcomes (e.g., choos
ing not to buy quality-adjusted life years, or QALYs, over a certain
cost).292 Thus, a source country's definition of quality will create
potential medical tourists out of those whose treatments fall on the
wrong side of a QALY-cost threshold. Equally, a country that sets
its QALY cutoff below its available resources will create health sur
pluses that are then available to treat tourists.
Quality of care issues have been raised by doctors in Germany
regarding patients who avoided waiting lists for kidney transplants
by visiting commercial transplantation centers in, for example, In
dia or Pakistan. The patients then returned to Germany with
problems based on substandard tissue matching practices that lead
to higher mortality rates than with "domestic" transplants. 293 Simi
larly, a survey of Australian plastic surgeons noted complications in
patients returning from inexpensive cosmetic surgery in Bangkok.
Reported problems included "'hideous scarring' and infections in
290. Joel Millman, How the Amish Drive Down Medical Costs, WALL ST. J., Feb.
21, 2006, at Bl, available at LEXIS.
291. Reinhardt et aI., supra note 139, at 13-15.
292. Helmut L. Karcher, German Doctors Protest Against "Organ Tourism", 313
BRIT. MED. J. 1282, 1282 (1996). For one critique, see generally John La Puma & Ed
ward F. Lawlor, Quality-Adjusted Life- Years: Ethical Implications for Physicians and
Policymakers, 263 JAMA 2917 (1990).
293. Karcher, supra note 292, at 1282.
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breast implants."294 One surveyed doctor labeled the procedures as
"'surgical roulette.' "295 In June 2006, before a Senate committee,
the president of the American Society of Plastic Surgeons testified,
"We are all aware of cases, which are reported in the media and
which confront some of my colleagues and other physicians, of pa
tients returning to this country with disfigurement and nearly fatal
infections associated with unaccredited hospitals and unlicensed
providers."296
The theoretical quality barrier to medical tourism (and to some
lesser extent health care outsourcing) is that the patient may experi
ence poorer health outcomes abroad and, in the event of a medical
mishap, reduced legal outcomes (compensation). At this stage,
there is simply no data with which to address this "quality" ques
tion. For every story about the risks of medical tourism there are
countervailing endorsements from satisfied patients297 or observa
tions that the adverse event rate at the private, tourist-oriented In
dian surgery centers is equivalent to the best U.S. facilities. 298
Certainly, medical tourists who suffer medical mishaps may
have to encounter an unfamiliar legal system. For example, the po
sition of the U.K. government, relying on case law that suggests the
National Health Service does not have a non-delegable duty to its
patients, is that medical tourists who go abroad for treatment under
the El12 scheme must rely on remedies, as against the treating pro
vider, offered by the courts of the place of treatment. 299 It may be
294. Warnings on Plastic Surgery Mistakes, THE AGE (Austl.), Jan. 17,2006, avail
able at http://www.theage.com.au/newsfNationallWarnings-on-plastic-surgery-mistakesl
2006/01l17/1137466979953.html (quoting Dr. Norm Olbourne); see also More Aus
tralians Heading Overseas for Surgery (Austl. Broadcasting Corp. television broadcast,
July 25, 2005) (transcript available at http://www.abc.net.aul7.30/content/2005/s1422042.
htm) (discussing complications following knee surgery on an Australian patient in
India).
295. Warnings on Plastic Surgery Mistakes, supra note 294 (quoting Dr. Norm
Olbourne).
296. The Globalization of Health Care: Can Medical Tourism Reduce Health Care
Costs? Hearing Before the S. Special Comm. on Aging, 109th Congo (2006) (statement
of Bruce Cunningham, Am. Soc'y of Plastic Surgeons), available at http://aging.senate.
gov/eventslhrI59bc.pdf.
297. See, e.g., The Globalization of Health Care: Can Medical Tourism Reduce
Health Care Costs? Hearing Before the S. Special Comm. on Aging, 109th Congo (2006)
(statement of Maggi Ann Grace, patient and patient advocate), available at http://aging.
senate.gov/eventslhrI59mg.pdf.
298. John Lancaster, Surgeries, Side Trips for 'Medical Tourists'; Affordable Care
at India's Private Hospitals Draws Growing Number of Foreigners, WASH. POST, Oct.
21, 2004, at AI, available at LEXIS.
299. Cara Guthrie & Hannah Volpe, Overseas Treatment for NHS Patients, 2006
J. PERS. INJ. L. 12, 15-16.
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the case that the dramatically lower costs of care in, say, India, are a
function of that country's lower malpractice recovery300 and lower
malpractice insurance costs,301 although that canard has been ex
posed regarding U.S. health care. 302 Injured tourists returning to
the United States, or domestic patients who, for some reason, can
not establish liability against the local arm of their offshore pro
vider, undoubtedly will face legal complications, such as jurisdiction
and enforcement, in excess of those that would occur in a purely
domestic setting. 303
Currently, the most likely barrier is information costs regard
ing quality. There are indeterminacies and, hence, substantial in
formation costs relating to the quality of offshore health and legal
services. 304 U.S. companies offshoring their HIT and disaggregated
services can protect their interests with appropriate contractual, ju
risdictional, and choice-of-Iaw provisions, much as they are com
pelled to protect their patients by "exporting" HIPAA
confidentiality and security requirements through "business associ
ate" agreements. 305 After the two reported extortion cases, tran
scription service agreements now include much stronger controls on
subcontracting. 306 Western providers are also likely to face fewer
legal problems when they use nearshoring because of the more
closely aligned legal cultures and clearer bilateral dispute resolution
practices.
Medical tourists, however, face far higher information costs.
Here, two scenarios suggest themselves. Either medical tourism
will continue unabated with the vast majority of patients encounter
ing no serious medical or legal adverse events, or quality disparities
Garud, supra note 4, at 319.
Lancaster, supra note 298.
302. See MICHELLE M. MELLO, ROBERT WOOD JOHNSON FOUND., UNDER
STANDING MEDICAL MALPRACTICE INSURANCE: A PRIMER (2006), available at http://
www.rwjf.org/publications/synthesis/reports_and_briefsIpdf/no8_primer.pdf.
303. See, e.g., McLean, supra note 58, at 247-55; Nathanial H. Hwang, You've Got
Mail- The Concerns of Electronically Outsourcing Radiological Services Overseas, 25 J.
LEG. MED. 469, 477-83 (2004).
304. Wachter, supra note 165, at 663-64.
305. See, e.g., Sarah E. Hazelwood et a!., Possibilities and Pitfalls of Outsourcing,
HEALTHCARE FIN. MGMT., Oct. 2005, at 44,45-46, available at http://www.findartic1es.
300.
301.

com/p/artic1es/mi_m3257/is_10_59/ai_n15777189.

306. BiIl Briggs, Offshore Outsourcing Poses Risks, HEALTH DATA MGMT., Feb.
2005, at 68, available at http://healthdatamanagement.com/html/currentlPastIssueStory.
cfm? Artic1eId=10505&issuedate=2005-02-01. For risk management strategies, see gen
erally Margaret Davino, Assessing Privacy Risk in Outsourcing, 75 J. AHIMA 42
(2004), available at http://library.ahima.orglxpedio/groups/public/documents/ahimalbok
1_022546.hcsp?dDocName=bok1_022546.
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will become a real or perceived barrier to tradable services. The
latter may prove to be the case with U.S. patients who have come to
rely on increasingly robust information about the quality of their
domestic providers, due to the report cards, outcomes reports, and
other data that Kristin Madison usefully describes as the products
of "market-facilitating regulation."307 If this group of potential
tourists steps back from foreign medical systems, their health insur
ers (if involved) or tourism intermediaries will have an incentive to
intervene and to demand quality comparability guarantees for their
customers. They may refuse to contract with offshore providers
that are not accredited by, say, Joint Commission InternationaP08
or may themselves provide insurance packages ensuring coverage
for offshore litigation or domestic remedial medical care. A paral
lel dynamic may emerge in the legal systems of tourist destinations.
While some underdeveloped countries may shore up their health
quality and compensation systems (as is already occurring in the
area of health data protection) to forestall protectionist regulation,
others may join a "race to the bottom" to better compete for tour
ists' hard currencies.
B.

Globalization and Free Trade

"Globalization" is one of our fledgling century's "magic"
words. It is also one that can mean different things to different peo
ple, including "economic liberalization" or "global integration."309
It is used here, and applied to health care, to denote the "increasing
interconnectedness of people and places";310 a connectedness that
"undermine[s] the importance of local and even national bounda
ries in many arenas of human endeavor."311
Kristin Madison, Regulating Health Care Quality in an Information Age, 40
(forthcoming 2007).
308. Joint Comm'n Int'l, About Joint Commission International, http://www.joint
commissioninternational.com/22758 (last visited Mar. 18, 2007); see also Mattoo &
Rathindran, supra note 284, at 366 (urging foreign providers to signal quality by passing
U.S. licensing examinations); Lee Hui Chieh, US Quality Controls for Hospitals in
S'pore, Aim Is to Improve Healthcare Quality and Boost Medical Hub Status, STRAITS
TIMES (Sing.), Nov. 2, 2005, available at 2005 WLNR 17712514 (Westlaw) (detailing
Joint Commission International accreditation of Singapore hospitals).
309. See, e.g., William Scheuerman, Globalization, in STANFORD ENCYCLOPEDIA
OF PHILOSOPHY (2006), http://plato.stanford.edu/entries/globalization;Globalization,in
WIKIPEDIA, http://en.wikipedia.org/wiki/Globalization (last visited Mar. 18, 2007).
310. Roy Smith, Access to Healthcare via Telehealth: Experiences from the Pacific,
3 PERSP. ON GLOBAL DEV. & TECH. 197, 198 (2004).
311. Scheuerman, supra note 309.
307.
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For health care, globalization can have both positive and nega
tive connotations. The positives are obvious. For example, public
health improves because improved communications increases ac
cess and the speed of access to worldwide research and alarms
about health threats. 312 The negative correlate is that the increased
personal interconnectedness of people increases the global impact
of public health threats, for example the SARS epidemic in 2003 or
bioterrorism. 313
International and regional trade agreements have had little im
pact on core U.S. health care delivery compared, for example, to
impacts on environmental law and policy. In the long term this may
change. The General Agreement on Trade in Services (GATSpI4 is
likely to increase cross-border trading of services and, as a result,
stimulate cross-border recognition of professional licensure. In
contrast, the Agreement on Trade-Related Aspects of Intellectual
Property Rights (TRIPSpls has the potential to negatively affect
some cross-border trade such as the reimportation of U.S.-pro
duced pharmaceuticals. 316 Other regional agreements such as the
Central America Free Trade Agreement (CAFTA)317 likely will
have similar impacts, both positive and negative. 318
312. Laura J. Nosek, Globalization's Costs to Healthcare: How Can We Pay the
Bill?, NURSING ADMIN. Q., Apr.-June 2004, at 116, 116-17.
313. Id. at 117-18; see also Nicholas Bakalar, Speed of the Spread of Flu is Linked
to Airline Travel, N.Y. TIMES, Sept. 12,2006, at F9, available at 2006 WLNR 15784725
(Westlaw). See generally Roy L. Simpson, Global Informing: Impact and Implications
of Technology in a Global Marketplace, NURSING ADMIN. Q., Apr.-June 2004, at 144,
147.
314. See generally World Trade Org., General Agreement on Trade in Services
(GATS), Annex lB, 33 I.L.M. 1125, 1167 (1994) [hereinafter "GATS"), available at
http://www. wto.org/english/docs_e/legal_e/26-gats. pdf.
315. See generally World Trade Org., Agreement on Trade-Related Aspects of
Intellectual Property Rights (TRIPS), Annex IC, 33 I.L.M. 1197 (1994), available at
http://www.wto.org/english/docs_e/legaLe/27-trips.pdf.
316. See generally Ellen R. Shaffer et aI., Global Trade and Public Health, 95 AM.
J. PUB. HEALTH 23 (2005).
317. See generally U.S. Dep't of Agric., Foreign Agric. Serv., U.S.-Dominican Re
public-Central America Free Trade Agreement (CAFTA-DR), available at http://www.
fas.usda.gov/itp/CAFTAIcafta.asp (last visited Mar. 16, 2007).
318. For services, see OFF. OF THE U.S. TRADE REPRESENTATIVE, CAFTA IS
NOT "ANTI-DENTIST"-STATE LICENSING REQUIREMENTS NOT AFFECTED (2005),
available at http://www.ustr.gov/assetslTrade_Agreements/BilateraIlCAFTAIBriefin~
Book/asset_upload_file876_7881.pdf. For pharmaceuticals, see OFF. OF THE U.S.
TRADE REPRESENTATIVE, CAFTA AND ACCESS TO MEDICINES (2005), available at
http://www.ustr.gov/assetslTrade_Agreements/BilateraIlCAFTA/Briefin~Book/assec

upload_file433_7198.pdf.

468

WESTERN NEW ENGLAND LAW REVIEW

[Vol. 29:421

The World Bank views globalization as the "[f]reedom and
ability of individuals and firms to initiate voluntary economic trans
actions with residents of other countries. "319 But the implications
of agreements like GATS, for example, on national health care sys
tems are still unclear. The agreement is subject to ongoing negotia
tions and specifically based on commitments and exceptions
scheduled by participating nations. In general terms, GATS calls
for liberalization in the trade of services. 32o According to Richard
D. Smith321 and Ian S. Mutchnick and colleagues,322 services323
likely to be liberalized include telehealth, medical tourism, foreign
investment in domestic health care businesses, and the temporary
movement across borders by health care workers. Smith suggests
that, at this stage in the development of GATS, direct investment
creating a foreign "commercial presence" is the "most critical."324
So far, examples of U.S. participation in establishing a global
health market have tended toward the embarrassing. For example,
the United States has taken the position that foreign price controls
result in U.S. consumers paying a disproportionate share of phar
maceutical R&D costS. 325 And in recent trade negotiations with
Australia, the United States leveraged access to its agricultural mar
ket to gain concessions from Australia on its domestic pharmaceuti
cal price controls. 326 For many Western countries, health care
"globalization" has been little more than a process for securing ac
cess to underdeveloped economies for their capital and health care
services, coupled with ensuring worldwide patent protection for
their pharmaceutical industries. 327
319. BRANKO MILANOVIC, CAN WE DISCERN THE EFFECT OF GLOBALIZATION
ON INCOME DISTRIBUTION? EVIDENCE FROM HOUSEHOLD SURVEYS 6 (2004), available
at http://www .worldbank.org/research/ineq uality/pdf/G LOB E8.pdf.
320. GATS, supra note 314, at 1168 (preamble).
321. Richard D. Smith, Foreign Direct Investment and Trade in Health Services: A
Review of the Literature, S9 Soc. SCI. & MED. 2313, 2314 (2004).
322. Ian S. Mutchnick et aI., Trading Health Services Across Borders: GATS, Mar
kets, And Caveats, HEALTH AFF., Jan. 2S, 200S, at WS-42, WS-4S, WS-47, available at
http://content.healthaffairs.orglcgi/reprin tlhlthaff. wS.42v1. pdf.
323. GATS, supra note 314, at 1169 (art. I, 2).
324. Smith, supra note 321, at 2318.
32S. Reinhardt et aI., supra note 139, at 17-18.
326. See generally Bob Burton, Australian Drug Pricing Scheme Under Pressure
in Free Trade Talks, 328 BRIT. MED. J. 247 (2004); Bob Burton, Australia Makes Con
cessions on Drug Approvals After US Pressure, 328 BRIT. MED. J. 42S (2004).
327. See generally Press Release, Doctors Without BorderslMedecins Sans
Frontieres, As WHO and UNAIDS Call For Global Treatment Scale-Up, MSF Asks:
Where Will the Essential Drugs Come From? (Mar. 28, 2006), available at http://www.
doctorswithoutborders.orglpr/2006/03-28-2006.cfm.
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Non-Market Constraints and Regulatory Dilemmas

Protectionism aside, today it is difficult to make a case for in
creased regulation of medical tourism, outsourcing, or arbitrage. In
the absence of negative evidence (for example, that medical tour
ism increases domestic health care costs because of required do
mestic remedial or follow-up treatments),328 it is arguable that
foreign-sourced, low-cost, high-quality care will stimulate global
health care and reduce the market failures seen in Western systems.
But the preceding discussion assumes a Western frame-for exam
ple, whether offshore clinical trials are a safe basis for U.S. drug
approval, or whether U.S. health data processed abroad retains in
tegrity. What has not been discussed is the impact on developing
countries of some of this tourist or offshoring activity.329
When Atul Gawande spent time in the hospitals of his family's
homeland he noted the relative helplessness of Indian health care in
the face of rapidly changing demographics-in particular, the rising
life expectancy of its patient population. He also was struck by the
contrast between poorly resourced and otherwise inadequate public
health care facilities and the high-quality private facilities that cater
to self-payers and medical tourists. 33o Although India spends 5.1
percent of its GDP on health care, less than 1 percent is spent on
public sector health. 331 Meanwhile, many Indian doctors view emi
gration or, at least, residencies in Western countries, as major and
realistic goals,332 significantly reducing the number of physicians in
domestic practice. 333 Not surprisingly, commentators in less-devel
328. See, e.g., Amelia Gentleman, Our Baby Joy, by Test- Tube Tourists who Flew
to India: Britons Risked Fury of Health Professionals at Home to Have Banned Multi
Embryo Implant, OBSERVER (U.K.), Mar. 26, 2006, available at 2006 WLNR 5055044
(Westlaw) (reporting objections to foreign IVF procedures counter-indicated in the
U.K. on the basis that the National Health Service will bear the cost of potentially
difficult multiple births and post-natal care).
329. The issue also has been raised in trade between industrialized countries. For
example, some Canadian patient advocacy groups oppose the Canada-U.S. drug trade
because of the impact on drug supplies and prices for Canadian patients. Canadian
Groups Ask for Ban on Web Pharmacies, crV.CA, Mar. 31 2004, http://www.ctv.ca/
servletlArticleN ews/story/CTVN ewsll 080740165689_67.
330. Atul Gawande, Dispatch from India, 349 NEW ENG. J. MED. 2383, 2383-86
(2003).
331. Id. at 2386; Fitzhugh Mullan, Doctors for the World: Indian Physician Emi
gration, 25 HEALTH AFF. 380, 382 (2006).
332. Gawande, supra note 330, at 2386.
333. Fitzhugh Mullan, The Metrics of the Physician Brain Drain, 353 NEW ENG. J.
MED. 1810, 1818 (2005), available at http://content.nejm.orglcgi/reprint/353/17/181O.pdf;
see also Christophe Segouin et aI., Editorial, Globalization in Health Care: Is Interna
tional Standardization of Quality a Step Toward Outsourcing?, 17 INT. J. QUALITY
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oped countries have questioned the impact of large numbers of
medical tourists (in reality a form of medical colonialism) on the
waiting lists for treatments for their own citizens.334
Similar issues arise with regard to clinical trials. The Western
philosophy behind trials involving human subjects is that they are
an expression of altruism-a few volunteering now for trials to later
benefit the many if the drug proves beneficial. This seems to be a
flawed concept when applied to offshore clinical trials. The practi
cal truth is that medically deprived patients in less-developed coun
tries are going to enter such trials in the hope that their personal
health future will benefit,335 Further, medicines tested in less-de
veloped countries often are designed for, or at least initially des
tined for, industrialized populations. At the very least, the
populations that participate in the trials should be guaranteed par
ticipation in any benefit and at an affordable price.
The dilemma, of course, is that at a macro level, less-developed
countries are looking to health tourists and outsourcing as ways to .
grow their health care and HIT economies. Their citizens may view
apparently beneficent but foreign regulation of activities in their
countries as examples of legal colonialism, as no less protectionist
than outright legal impediments to travel or offshoring.
CONCLUSION

The health care systems of the United States and other West
ern countries face physician and nursing shortages; spiraling domes
tic health care costs; the attraction of pharmaceutical arbitrage; the
growing importance of portable, border-agnostic HIT; and possible
increases in discretionary patient spending because of consumer-di
rected health care. These factors suggest that medical tourism and
health care outsourcing will expand in the near future. Given con
cerns about health quality and data protection, it is perhaps surpris
ing that these phenomena are essentially unregulated.
Of the few legal obstructions to tourism that do exist, most are
transitional, as regional systems such as the European Union dis
mantle remaining interstate barriers. Outsourcing is essentially un
regulated and is likely to remain that way. While international and
HEALTH CARE 277, 277-79 (2005). A similar phenomenon applies to domestic nursing
populations when developed countries liberalize their immigration policies. See, e.g.,
Dugger, supra note 265.
334. Swati Bhattacharjee, Noor Fatima and Medical Tourism, 101 J. INDIAN MED.
ASS'N 497, 497 (2003); Garud, supra note 4, at 319.
335. See Kahn, supra note 247.
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regional trade agreements have not noticeably accelerated tourism
or outsourcing, they will impede outwardly protectionist regulation
or legislation proposed in knee-jerk reaction to isolated media re
ports of adverse events suffered by tourists or offshore data
mishaps.
In considering whether these phenomena are sub-optimally
regulated, a variety of transnational or potentially transnational
health care incidents can be written off as outliers. Thus, we can
probably leave for another day the questions about how our regula
tory systems should react to a used pacemaker being sold on an
online auction site,336 international robotic surgery,337 or even on
line organ matching. 338 Of the areas where more robust patient
protections are necessary, the most obvious is in data protection
and, specifically, ensuring both that offshore data extenders are
covered by U.S. confidentiality and security rules, and that enforce
ment of those rules is effective. Here, however, the U.S. legal defi
ciency may be less a function of an offshore location and more of
the general inadequacies of the current medical privacy and confi
dentiality protections. 339 If the political will can be found to revisit
medical privacy and confidentiality, then its extraterritorial effect
should be made explicit. Other, perhaps less pressing issues, such
as real or perceived quality deficiencies, are likely to be met near
term with self-regulatory "patches," such as codes of conduct and
accreditation.
Over the long term it is difficult to see a truly global health
care market replete with effective transnational patient-protective
laws. As a result, there may come a time when domestic legal sys
tems will be forced to address some of the issues raised here. When
that time comes, it is imperative that U.S. regulation is sensitive to
336. See Jennifer Ryan, Pirated Pacemaker Exposes Failings, E. V ALLEY TRIB.
(Phoenix), Mar. 20, 2005, available at http://www.eastvalleytribune.com/index.php?sty=
38232 (noting the sale of stolen pacemakers on e8ay, one of which was implanted into a
patient in Arizona).
337. McLean, supra note 58, at 243-45; cf J. Paul Finn et aI., M R Imaging with
Remote Control: Feasibility Study in Cardiovascular Disease, 241 RADIOLOGY 528, 528
37 (2006).
338. See, e.g., MatchingDonors, http://www.matchingdonors.com (last visited
Mar. 18, 2007) (connecting organ donors with patients in need). See generally Joyce
Howard Price, Organ Donors Matched Online, WASH. TIMES, June 11, 2006, at A02,
available at 2006 WLNR 10051388 (Westlaw); Pakistan 'Kidney Bazaar' Thrives,
CNN.cOM, Nov. 17,2006 (on file with Western New England Law Review).
339. See generally Terry & Francis, Ensuring the Privacy and Confidentiality of
Electronic Health Records, supra note 154.
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the domestic economies and policies of our trading partners. To
avoid accusations of legal colonialism, we need to commence a dia
logue as to how best to achieve any future regulation.

